image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
a5eedfbfa8eb069fd2e0fcdb947decbd313f6affe3b3b04fcd8c402e2459b884.png | complex | <table><tr><td rowspan="2">Urea Concentration (M)</td><td colspan="7">Mn Content (%)</td></tr><tr><td>5</td><td>10</td><td>20</td><td>40</td><td>60</td><td>80</td><td>100</td></tr><tr><td>0.5</td><td>4.59</td><td>1.66</td><td>3.386</td><td>0.896</td><td>3.808</td><td>3.585</td><td>2.488</td></tr><tr><td>1.0</td><td>3.0... | <table><tr><td rowspan="2">Urea Concentration (M)</td><td colspan="3">Mn Content (%)</td></tr><tr><td>5</td><td>10</td><td>20</td></tr><tr><td>0.5</td><td>4.59</td><td>1.66</td><td>3.386</td></tr><tr><td>1.0</td><td>3.089</td><td>0.685</td><td>2.964</td></tr><tr><td>2.0</td><td>2.732</td><td>2.439</td><td>2.135</td></t... | <table><tr><td colspan="4">Mn Content (%)</td></tr><tr><td>40</td><td>60</td><td>80</td><td>100</td></tr><tr><td>0.896</td><td>3.808</td><td>3.585</td><td>2.488</td></tr><tr><td>0.136</td><td>2.739</td><td>1.973</td><td>2.385</td></tr><tr><td>0.085</td><td>2.256</td><td>2.244</td><td>2.403</td></tr></table> |
ffbaff2cfee3c3bc840fdae42cf3396502ec0136d0c1f835a83051a6603f277b.png | complex | <table><tr><td>Clinical Features</td><td colspan="2">MBD5-specific mutation<sup>20,22–24</sup></td><td colspan="2">2q23.1 Deletion<sup>20,22–24</sup></td><td>Case in this study</td></tr><tr><td> </td><td>Number</td><td>Percentage</td><td>Number</td><td>Percentage</td><td>+, present; - absent</td></tr><tr><t... | <table><tr><td>Clinical Features</td><td colspan="2">MBD5-specific mutation20,22–24</td><td colspan="2">2q23.1 Deletion20,22–24</td><td>Case in this study</td></tr><tr><td></td><td>Number</td><td>Percentage</td><td>Number</td><td>Percentage</td><td>+, present; - absent</td></tr><tr><td>Neurological</td><td></td><td></t... | <table><tr><td>Clinical Features</td><td colspan="2">MBD5-specific mutation20,22–24</td><td colspan="2">2q23.1 Deletion20,22–24</td><td>Case in this study</td></tr><tr><td></td><td>Number</td><td>Percentage</td><td>Number</td><td>Percentage</td><td>+, present; - absent</td></tr><tr><td>Clinodactyly, 5th finger</td><td>... |
679f06a83ff804a214dbbba312728a1730063003fc58b59cb2f4e7cbb2d4a71d.png | complex | <table><tr><td></td><td colspan="3">Dementia can be cured through divine healing, such as through prayer</td><td colspan="3">People with dementia should be placed in ‘homes’</td></tr><tr><td></td><td><i>B</i></td><td>β</td><td><i>t</i></td><td><i>B</i></td><td>β</td><td><i>t</i></td></tr><tr><td>A... | <table><tr><td></td><td colspan="3">Dementia can be cured through divine healing, such as through prayer</td><td colspan="3">People with dementia should be placed in ‘homes’</td></tr><tr><td></td><td>B</td><td>β</td><td>t</td><td>B</td><td>β</td><td>t</td></tr><tr><td>Age</td><td>0.013</td><td>0.013</td><td>0.333</td><... | <table><tr><td></td><td colspan="2">R2=0.091</td><td></td><td colspan="2">R2=0.034</td><td></td></tr><tr><td></td><td colspan="3">Adjusted R square=0.086</td><td colspan="3">Adjusted R square=0.029</td></tr><tr><td></td><td colspan="2">F=18.810***</td><td></td><td colspan="2">F=6.730***</td><td></td></tr></table> |
09b3ace1d198fa113b5a51f8ad5b06ae2576c63fc9c692ab09fb2bcbef7032e9.png | complex | <table><tr><td></td><td colspan="5">Domains of quality of life <sup>d</sup></td></tr><tr><td>Characteristics</td><td>Physical Mean (SD)</td><td>Psychological Mean (SD)</td><td>Social Mean (SD)</td><td>Environmental Mean (SD)</td><td>Global Mean (SD)</td></tr><tr><td>Diagnosis</td><td></td><td></td><td></td><td></td><td... | <table><tr><td></td><td colspan="5">Domains of quality of life d</td></tr><tr><td>Characteristics</td><td>Physical Mean (SD)</td><td>Psychological Mean (SD)</td><td>Social Mean (SD)</td><td>Environmental Mean (SD)</td><td>Global Mean (SD)</td></tr><tr><td>Diagnosis</td><td></td><td></td><td></td><td></td><td></td></tr>... | <table><tr><td>Female</td><td>55.25 (19.95)</td><td>51.9 (19.28)</td><td>60.59 (18.25)</td><td>52.33 (16.41)</td><td>54.78 (22.60)</td></tr><tr><td>Education a</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Low</td><td>54.84 (19.31)***</td><td>53.24 (18.50)***</td><td>61.87 (17.66)***</td><td>52.59 (16.1... |
f3964f6a2426fcfc2472ed4a0d3ba993082709aa88fa388f3f8fbed4c5b126ba.png | simple | <table><tr><td></td><td>No cancer</td><td>Cancer</td><td>Total</td></tr><tr><td>Mammogram (+)</td><td>20</td><td>10</td><td>32</td></tr><tr><td>Mammogram (−)</td><td>21</td><td>1</td><td>21</td></tr><tr><td>Total</td><td>41</td><td>11</td><td>52</td></tr><tr><td>Measure</td><td>Sn = 91 %</td><td>Sp = 51 %</td><td... | <table><tr><td></td><td>No cancer</td><td>Cancer</td><td>Total</td></tr><tr><td>Mammogram (+)</td><td>20</td><td>10</td><td>32</td></tr><tr><td>Mammogram (−)</td><td>21</td><td>1</td><td>21</td></tr></table> | <table><tr><td>Total</td><td>41</td><td>11</td><td>52</td></tr><tr><td>Measure</td><td>Sn = 91 %</td><td>Sp = 51 %</td><td></td></tr></table> |
068d59979b22ae62902570af3c8c6b3edac99fc0d20bdd3dd8c558651b8482ea.png | complex | <table><tr><td colspan="8">HtMM</td></tr><tr><td colspan="8">Normalized jerk</td></tr><tr><td colspan="4">Dominant</td><td colspan="4">Nondominant</td></tr><tr><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td></tr><tr><td><i>R</i> = ... | <table><tr><td colspan="8">HtMM</td></tr><tr><td colspan="8">Normalized jerk</td></tr><tr><td colspan="4">Dominant</td><td colspan="4">Nondominant</td></tr><tr><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td></tr><tr><td>R = 0.75p <... | <table><tr><td colspan="8">HtMM</td></tr><tr><td colspan="4">Dominant</td><td colspan="4">Nondominant</td></tr><tr><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td></tr><tr><td>R = −0.43p = 0.010</td><td>R = −0.63p = 0.004</td><td>R ... |
afc89447d928941bfeee5482cecbf3f03e949cdb4abc00b7b9660b8f5580223a.png | complex | <table><tr><td>Group</td><td>Ace genotype</td><td>Presence</td><td>Absence</td><td>Total</td><td>X<sup>2</sup></td><td>p</td><td>X<sup>2</sup></td><td>p</td><td>OR (CI 5-95%)</td></tr><tr><td rowspan="3">Without taking <i>CFTR</i> mutation into account</td><td>I/I</td><td>8</td><td>64</td><td>72</td><td rowspan="3">8.6... | <table><tr><td>Group</td><td>Ace genotype</td><td>Presence</td><td>Absence</td><td>Total</td><td>X2</td><td>p</td><td>X2</td><td>p</td><td>OR (CI 5-95%)</td></tr><tr><td rowspan="3">Without taking CFTR mutation into account</td><td>I/I</td><td>8</td><td>64</td><td>72</td><td rowspan="3">8.654</td><td rowspan="3">0.013<... | <table><tr><td rowspan="2">No identified CFTR mutation</td><td>I/D</td><td>2</td><td>16</td><td>18</td><td rowspan="2">0.530</td><td rowspan="2">0.767</td><td>0.204</td><td>1.00</td><td>0.656 (0.107 - 4.041)</td></tr><tr><td>D/D</td><td>1</td><td>3</td><td>4</td><td>0.438</td><td>0.93</td><td>2.267 (0.196 - 26.27)</td>... |
7ba2d83e38f75961abc498dd6749224fd2512970b2db0fb9325481698ff5817f.png | complex | <table><tr><td rowspan="2"><i>Diabetes</i></td><td rowspan="2"><i>Gender</i></td><td rowspan="2"><i>n</i></td><td colspan="3"><i>Box-counting FD (GrayScale)</i></td></tr><tr><td>Mean FD</td><td>95% CI</td><td><i>p</i><sup>†</sup></td></tr><tr><td rowspan="2">No</td><td>Female</td><td>71</td><td>2.4203</td><td>2.4... | <table><tr><td rowspan="2">Diabetes</td><td rowspan="2">Gender</td><td rowspan="2">n</td><td colspan="3">Box-counting FD (GrayScale)</td></tr><tr><td>Mean FD</td><td>95% CI</td><td>p†</td></tr><tr><td rowspan="2"></td><td>Female</td><td>71</td><td>2.4203</td><td>2.4164 - 2.4242</td><td rowspan="2"></td></tr><tr><td>M</... | <table><tr><td>No</td><td>ale</td><td>5</td><td>2.4251</td><td>4217 - 2.4284</td><td rowspan="3">0.052</td></tr><tr><td rowspan="2">Yes</td><td>Female</td><td>12</td><td>2.4308</td><td>2.4214 - 2.4402</td></tr><tr><td>Male</td><td>11</td><td>2.4499</td><td>2.4401 - 2.4598</td></tr></table> |
f352d392710200946c50e1af4e88caf6158786301e0171e21b391e297aa66e22.png | simple | <table><tr><td> </td><td>CHD group (<i>n</i> = 45)</td><td>Healthy group (<i>n</i> = 15)</td><td><i>P</i> value</td></tr><tr><td>Age</td><td>59.24 ± 7.87</td><td>57.53 ± 4.47</td><td>0.304</td></tr><tr><td>Gender (male/female)</td><td>33/12</td><td>7/8</td><td>0.058</td></tr></table> | <table><tr><td></td><td>CHD group (n = 45)</td><td>Healthy group (n = 15)</td><td>P value</td></tr></table> | <table><tr><td>Age</td><td>59.24 ± 7.87</td><td>57.53 ± 4.47</td><td>0.304</td></tr><tr><td>Gender (male/female)</td><td>33/12</td><td>7/8</td><td>0.058</td></tr></table> |
1303fff38894a702373f96796dec19b28af722ab59ff59afe9532cc4719ee88f.png | complex | <table><tr><td>Predictor</td><td colspan="4">Digit span backward</td><td colspan="4">Letter-number sequencing</td></tr><tr><td></td><td>Df</td><td><i>F</i>-value</td><td><i>p</i>-value</td><td>η<sup>2</sup><sub><i>p</i></sub></td><td>Df</td><td><i>F</i>-value</td><td><i>p</i>-value</td><td>η<sup>2</sup><sub><... | <table><tr><td>Predictor</td><td colspan="4">Digit span backward</td><td colspan="4">Letter-number sequencing</td></tr><tr><td></td><td></td><td>F-</td><td>p-value</td><td>η</td><td>D</td><td>F-va</td><td>p</td><td>η2p</td></tr></table> | <table><tr><td></td><td>Df</td><td>value</td><td></td><td>2p</td><td>f</td><td>lue</td><td>-value</td><td></td></tr><tr><td>Group</td><td>1</td><td>0.56</td><td>0.46</td><td>0.11</td><td>1</td><td>0.64</td><td>0.43</td><td>0.10</td></tr><tr><td>Score</td><td>1</td><td>3.45</td><td>0.07</td><td>0.15</td><td>1</td><td>7.... |
f30ae562cf6fb8777c4018602d19e224fbf0e38fedfbed4757a3564ccf429a66.png | complex | <table><tr><td></td><td colspan="3">No FamPlex</td><td colspan="3">With FamPlex</td></tr><tr><td>Rank</td><td>Entity Text</td><td>Count</td><td>% of Total</td><td>Entity Text</td><td>Count</td><td>% of Total</td></tr><tr><td>1</td><td>NF-kappaB</td><td>18,381</td><td>3.78</td><td>PKCzeta</td><td>222</td><td>0.24</td></... | <table><tr><td></td><td colspan="3">No FamPlex</td><td colspan="3">With FamPlex</td></tr><tr><td>Rank</td><td>Entity Text</td><td>Count</td><td>% of Total</td><td>Entity Text</td><td>Count</td><td>% of Total</td></tr><tr><td>1</td><td>NF-kappaB</td><td>18,381</td><td>3.78</td><td>PKCzeta</td><td>222</td><td>0.24</td></... | <table><tr><td>8</td><td></td><td>42</td><td>.32</td><td>integrin</td><td>7</td><td>14</td></tr><tr><td>9</td><td>c-Src</td><td>1362</td><td>0.28</td><td>p38alpha</td><td>126</td><td>0.14</td></tr><tr><td>10</td><td>histone H3</td><td>1347</td><td>0.28</td><td>CD4+</td><td>124</td><td>0.14</td></tr></table> |
9419fe23ddc68d08038a8c9124b9c5c473d5c714f2d0f69e9f2d40472c9b05a7.png | complex | <table><tr><td> </td><td colspan="3"><i>2008</i></td><td colspan="3"><i>2009</i></td><td colspan="3"><i>2010</i></td><td colspan="3"><i>2011</i></td></tr><tr><td><i>Province</i></td><td><i>Cattle</i></td><td><i>Goats</i></td><td><i>Sheep</i></td><td><i>Cattle</i></td><td><i>Goats</i></td><td><i>Sheep</i></td><td><i>Cat... | <table><tr><td></td><td colspan="3">2008</td><td colspan="3">2009</td><td colspan="3">2010</td><td colspan="3">2011</td></tr></table> | <table><tr><td>Province</td><td>Cattle</td><td>Goats</td><td>Sheep</td><td>Cattle</td><td>Goats</td><td>Sheep</td><td>Cattle</td><td>Goats</td><td>Sheep</td><td>Cattle</td><td>Goats</td><td>Sheep</td></tr><tr><td>Limpopo</td><td>2.33</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>0.02</td><td></... |
079715311bda10ed1cea9dcc55a6cb3a6ece45122cb4e2ec8504931c923d96a4.png | simple | <table><tr><td><i>Gene</i></td><td><i>Disease</i></td><td><i>Mode of </i><i>inheritance</i></td><td><i>Stroke mechanism</i></td></tr><tr><td><i>GAL</i></td><td><i>Fabry's disease</i></td><td><i>X-linked</i></td><td><i>Large-artery disease and small-vessel disease</i></td></tr><tr><td><i>NOTCH3</i></td><td><i>CADASIL</i... | <table><tr><td>Gene</td><td>Disease</td></tr><tr><td>GAL</td><td>Fabry's disease</td></tr><tr><td>NOTCH3</td><td>CADASIL</td></tr><tr><td>HBB</td><td>Sickle-cell disease</td></tr><tr><td>CBS and others</td><td>Homocystinuria</td></tr><tr><td>mtDNA</td><td>MELAS</td></tr><tr><td>FBN1</td><td>Marfan syndrome</td></tr><tr... | <table><tr><td>Mode of inheritance</td><td>Stroke mechanism</td></tr><tr><td>X-linked</td><td>Large-artery disease and small-vessel disease</td></tr><tr><td>AD</td><td>Small-vassel disease</td></tr><tr><td>AR</td><td>Large-artery disease, small-vessel disease, haemodynamic insufficiency</td></tr><tr><td>AR</td><td>Larg... |
2e9f15b9b04f3c98581f4c57a001a8f1fa4519d2e71d1341e1e4b59a69a9a5ff.png | complex | <table><tr><td rowspan="2">Fungi</td><td colspan="8">Minimum fungicidal concentrations of ethanol extract of <i>Cleome gynandra</i> in mg/ml</td><td colspan="2">Controls</td></tr><tr><td>0.5</td><td>0.25</td><td>0.125</td><td>0.0625</td><td>0.0313</td><td>0.0156</td><td>0.00781</td><td>0.00391</td><td>−ve ctrl</t... | <table><tr><td rowspan="2">Fungi</td><td colspan="5">Minimum fungicidal concentrations of ethanol extract of Cleome gynandra in mg/ml</td></tr><tr><td>0.5</td><td>0.25</td><td>0.125</td><td>0.0625</td><td>0.0313</td></tr><tr><td>Mc</td><td>Nfgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td></tr><tr><td>Tm</td><td... | <table><tr><td colspan="3">Minimum fungicidal concentrations of ethanol extract of Cleome gynandra in mg/ml</td><td colspan="2">Controls</td></tr><tr><td>0.0156</td><td>0.00781</td><td>0.00391</td><td>−ve ctrl</td><td>+ ctrl</td></tr><tr><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Nfgo</td></tr><tr><td>Fgo</td>... |
88091677bd29de7e8fd88b58e0eb1ed257493997ae57f50df166c358d225364d.png | simple | <table><tr><td>Testing completed</td><td><i>N</i> (%)</td></tr><tr><td>Actionable</td><td>92 (65%)</td></tr><tr><td>Not actionable or informative</td><td>35 (25%)</td></tr><tr><td>Informative</td><td>11 (8%)</td></tr><tr><td>No reportable results</td><td>2 (1%)</td></tr><tr><td>Test failed</td><td>1 (< 1%)</td></tr>... | <table><tr><td>Testing completed</td></tr><tr><td>Actionable</td></tr><tr><td>Not actionable or informative</td></tr><tr><td>Informative</td></tr><tr><td>No reportable results</td></tr><tr><td>Test failed</td></tr></table> | <table><tr><td>N (%)</td></tr><tr><td>92 (65%)</td></tr><tr><td>35 (25%)</td></tr><tr><td>11 (8%)</td></tr><tr><td>2 (1%)</td></tr><tr><td>1 (< 1%)</td></tr></table> |
764844cfbb1981fa3274cac0dff6391c03e174de7f1a2bd1a3aaf6202a7d35cf.png | complex | <table><tr><td colspan="2">Escala de risco de sangramento RIETE modificada</td></tr><tr><td>Variável</td><td>Pontos</td></tr><tr><td>Hemorragia maior recente (< 1 mês)</td><td>2</td></tr><tr><td>Creatinina > 1,2 mg/dL</td><td>1,5</td></tr><tr><td>Anemia</td><td>1,5</td></tr><tr><td>Câncer</td><t... | <table><tr><td>Escala de risco de sangramento RIETE modificada</td></tr><tr><td>Variável</td></tr><tr><td>Hemorragia maior recente (< 1 mês)</td></tr><tr><td>Creatinina > 1,2 mg/dL</td></tr><tr><td>Anemia</td></tr><tr><td>Câncer</td></tr><tr><td>Idade > 75 anos</td></tr><tr><td>Risco baixo: 0; Risco intermediário: ... | <table><tr><td>Escala de risco de sangramento RIETE modificada</td></tr><tr><td>Pontos</td></tr><tr><td>2</td></tr><tr><td>1,5</td></tr><tr><td>1,5</td></tr><tr><td>1</td></tr><tr><td>5</td></tr><tr><td>Risco baixo: 0; Risco intermediário: 1-4; Risco alto: > 4</td></tr></table> |
3fc65e06ca6c36f2c9f1dd26f3ab6fd9382af047a2d83d2a59f06fcf35cac3fa.png | complex | <table><tr><td></td><td colspan="3">Percentage reporting ‘never’ undertaking measure for reducing risk of violence</td><td></td></tr><tr><td></td><td>M</td><td>F</td><td>N</td><td>Significance χ<sup>2</sup></td></tr><tr><td>Check patient notes in advance</td><td>52</td><td>37</td><td>620</td><td>p<.... | <table><tr><td></td><td colspan="3">Percentage reporting ‘never’ undertaking measure for reducing risk of violence</td><td></td></tr><tr><td></td><td>M</td><td>F</td><td>N</td><td>Significance χ2</td></tr><tr><td>Check patient notes in advance</td><td>52</td><td>37</td><td>620</td><td>p<.001</td></tr><tr><td>Leave door... | <table><tr><td></td><td colspan="3">Percentage reporting ‘never’ undertaking measure for reducing risk of violence</td><td></td></tr><tr><td></td><td>M</td><td>F</td><td>N</td><td>Significance χ2</td></tr><tr><td>ompanied on visits to certain patients</td><td>7</td><td></td><td></td><td>.005</td></tr><tr><td>Leaving vi... |
b8303fb9f5d52cac87ac16d9512c0a608f7076e87f0c92d333b19f7f97743dce.png | complex | <table><tr><td>Pt</td><td>Chromosome</td><td>Probes/libraries</td><td>Band localization</td><td>Genomic Localization (bp) (hg19)</td></tr><tr><td>1</td><td>8</td><td>AML1/ETO<sup>a</sup>WCP 1<sup>b</sup></td><td>designed for t(8;21)Whole chromosome paint library</td><td>–</td></tr><tr><td rowspan="2">2</td><td>2<... | <table><tr><td>Pt</td><td>Chromosome</td><td>Probes/libraries</td><td>Band localization</td><td>Genomic Localization (bp) (hg19)</td></tr><tr><td>1</td><td>8</td><td>AML1/ETOaWCP 1b</td><td>designed for t(8;21)Whole chromosome paint library</td><td>–</td></tr></table> | <table><tr><td>Pt</td><td>Chromosome</td><td>Probes/libraries</td><td>Band localization</td><td>Genomic Localization (bp) (hg19)</td></tr><tr><td rowspan="2">2</td><td>2</td><td>WCP 2bCTD-2314L14cCTD-2599D22cALKdCTD-3028D11 cCTD-2232H14cCTD-2566H13cCTD-2532N8cCTD-2371H10cCTD-2382F21cCTD-2052G24cCTD-3058K15c</td><td>Who... |
06e59ca022e490995b3744620905645031b87bcf76f076b54f513d84a7729a00.png | simple | <table><tr><td>FIRST GENE (REFSEQ ACCESSION NUMBER)</td><td>FIRST GENE (AHR BINDING SITES)</td><td>FIRST GENE (BINDING SITES OF OTHER TFS)</td><td>SECOND GENE (REFSEQ ACCESSION NUMBER)</td><td>SECOND GENE (AHR BINDING SITES)</td><td>SECOND GENE (BINDING SITES OF OTHER TFS)</td></tr><tr><td>NM_003928</td><td>-</td><td>-... | <table><tr><td>FIRST GENE (REFSEQ ACCESSION NUMBER)</td><td>FIRST GENE (AHR BINDING SITES)</td><td>FIRST GENE (BINDING SITES OF OTHER TFS)</td><td>SECOND GENE (REFSEQ ACCESSION NUMBER)</td><td>SECOND GENE (AHR BINDING SITES)</td><td>SECOND GENE (BINDING SITES OF OTHER TFS)</td></tr><tr><td>NM_003928</td><td>-</td><td>-... | <table><tr><td>FIRST GENE (REFSEQ ACCESSION NUMBER)</td><td>FIRST GENE (AHR BINDING SITES)</td><td>FIRST GENE (BINDING SITES OF OTHER TFS)</td><td>SECOND GENE (REFSEQ ACCESSION NUMBER)</td><td>SECOND GENE (AHR BINDING SITES)</td><td>SECOND GENE (BINDING SITES OF OTHER TFS)</td></tr><tr><td>NM_138446</td><td>1</td><td>-... |
2009d6ddd858d4051f6b3588c8295ec3e123c01400fc1c40703930ffe5d77978.png | simple | <table><tr><td>Plant Part</td><td>Subject of Study</td><td>Effect</td><td>Reference</td></tr><tr><td>ethyl acetate extract of the leaves</td><td>lung A549 cancer cells</td><td>mitochondrial-mediated apoptosis, cell cycle arrest at G<sub>1</sub> phase</td><td>[83]</td></tr><tr><td>ethyl acetate extract of the leaves</td... | <table><tr><td>Plant Part</td><td>Subject of Study</td></tr><tr><td>ethyl acetate extract of the leaves</td><td>lung A549 cancer cells</td></tr><tr><td>ethyl acetate extract of the leaves</td><td>colon HT-29 and HCT-116 cancer cells</td></tr><tr><td>water extract of the leaves</td><td>rat’s prostate</td></tr><tr><td>et... | <table><tr><td>Effect</td><td>Reference</td></tr><tr><td>mitochondrial-mediated apoptosis, cell cycle arrest at G1 phase</td><td>[83]</td></tr><tr><td>mitochondrial-mediated apoptosis, cell cycle arrest at G1 phase, suppression of migration and invasion</td><td>[84]</td></tr><tr><td>reduction of prostate size</td><td>[... |
86ce7f81a64b2bc71f48f0e8750b87f2ea25657acc9b0b0ac1670ad7aae27c86.png | simple | <table><tr><td>Number</td><td>Gender</td><td>Age</td><td>Treatment</td><td>Diagnosis of infection</td><td>Bacterial etiology</td><td>Days of infection detected after TACE and/or RFA</td><td>PCT on day of fever</td><td>Peak PCT within 7 days</td><td>Outcome of infection</td></tr><tr><td>1</td><td>M</td><td>57</td><td>TA... | <table><tr><td>Number</td><td>Gender</td><td>Age</td><td>Treatment</td><td>Diagnosis of infection</td><td>Bacterial etiology</td><td>Days of infection detected after TACE and/or RFA</td><td>PCT on day of fever</td><td>Peak PCT within 7 days</td><td>Outcome of infection</td></tr><tr><td>1</td><td>M</td><td>57</td><td>TA... | <table><tr><td>Number</td><td>Gender</td><td>Age</td><td>Treatment</td><td>Diagnosis of infection</td><td>Bacterial etiology</td><td>Days of infection detected after TACE and/or RFA</td><td>PCT on day of fever</td><td>Peak PCT within 7 days</td><td>Outcome of infection</td></tr><tr><td>6</td><td>M</td><td>73</td><td>TA... |
0480358c0e4b42e5ba9948a191c8ed18d9525fedcd35ee8e66fccaf1b5516435.png | simple | <table><tr><td>Type of Gholonj</td><td>Traditional term</td><td>Type of obstruction</td><td>Pathology</td></tr><tr><td>Inflammatory Gholonj</td><td>Gholonj-e-varami</td><td>Non mechanical</td><td>Inflammation in the intestinal wall or surrounding organs</td></tr><tr><td>Secretory Gholonj</td><td>Gholonj-e-balghami</td>... | <table><tr><td>Type of Gholonj</td><td>Traditional term</td><td>Type of obstruction</td><td>Pathology</td></tr><tr><td>Inflammatory Gholonj</td><td>Gholonj-e-varami</td><td>Non mechanical</td><td>Inflammation in the intestinal wall or surrounding organs</td></tr><tr><td>Secretory Gholonj</td><td>Gholonj-e-balghami</td>... | <table><tr><td>Type of Gholonj</td><td>Traditional term</td><td>Type of obstruction</td><td>Pathology</td></tr><tr><td>Torsion Gholonj</td><td>Gholonj-e-eltevaee</td><td>Mechanical</td><td>Intestinal torsion or bowel herniation</td></tr></table> |
cd381abe4a4c5d0e9cee93798a4b514d4b0d330038c02c5bbe2a62f07e57d996.png | complex | <table><tr><td></td><td colspan="3">TGF-β1 Release</td><td></td><td colspan="3">BDNF Release</td><td></td></tr><tr><td>LPS</td><td><i>E. coli</i></td><td></td><td><i>V. vulnificus</i></td><td></td><td><i>E. coli</i></td><td></td><td><i>V. vulnificus</i></td><td></td></tr><tr><td>(ng/mL)</td><td>(pg/mL)</td><td><i>... | <table><tr><td></td><td colspan="3">TGF-β1 Release</td><td></td><td colspan="3">BDNF Release</td><td></td></tr><tr><td>LPS</td><td>E. coli</td><td></td><td>V. vulnificus</td><td></td><td>E. coli</td><td></td><td>V. vulnificus</td><td></td></tr><tr><td>(ng/mL)</td><td>(pg/mL)</td><td>n1</td><td>(pg/mL)</td><td>n1</td><t... | <table><tr><td>0</td><td>319.7 ± 50.1</td><td>3</td><td>319.7 ± 50.1</td><td>3</td><td>0</td><td>2</td><td>0</td><td>2</td></tr><tr><td>0.1</td><td>424.3 ± 40.3</td><td>3</td><td>386 ± 16.0</td><td>2</td><td>5.1 ± 4.4</td><td>2</td><td>1.4 ± 0.8</td><td>2</td></tr><tr><td>1</td><td>363.3 ± 36</td><td>3</td><td>419 ± 66... |
a4387ae8e2afc2cb28086db0dbf096f8f595102fd891db733a30fc458297968e.png | complex | <table><tr><td colspan="2">Characteristics</td><td>Orifice involved (n=138)</td><td>Non-Orifice involved (n=1221)</td><td>Total (n=1359)</td><td>P</td></tr><tr><td colspan="2">Age (Mean ± SD)</td><td>65.1±10.5</td><td>63.4±11.7</td><td>63.5±11.6</td><td>0.087</td></tr><tr><td colspan="2">Follow-up, ... | <table><tr><td colspan="2">Characteristics</td><td>Orifice involved (n=138)</td><td>Non-Orifice involved (n=1221)</td><td>Total (n=1359)</td></tr><tr><td colspan="2">Age (Mean ± SD)</td><td>65.1±10.5</td><td>63.4±11.7</td><td>63.5±11.6</td></tr><tr><td colspan="2">Follow-up, months (mean ± IQR)*</td><td>45.5 (9–68)</td... | <table><tr><td>P</td></tr><tr><td>0.087</td></tr><tr><td>0.721</td></tr><tr><td></td></tr><tr><td rowspan="2">0.214</td></tr><tr></tr><tr><td></td></tr><tr><td></td></tr><tr><td rowspan="2">0.067</td></tr><tr></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td rowspan="2">0.565</td></tr><tr></tr><tr><td>... |
f6a1a42693b8d2c2a6159b0b9ff1852998db81a535a2c8fa272df325a3f59322.png | simple | <table><tr><td></td><td><i>E</i>/MPa</td><td><i>μ</i></td><td><i>α</i></td><td><i>K</i>/MPa</td></tr><tr><td>Theory values</td><td>2157</td><td>0.2</td><td>0.165872</td><td>0.875726</td></tr><tr><td>Identified values by GA</td><td>2135</td><td>0.182</td><td>0.171365</td><td>0.853471</td></tr><tr><td>Relative ... | <table><tr><td></td><td>E/MPa</td><td>μ</td><td>α</td><td>K/MPa</td></tr><tr><td>Theory values</td><td>2157</td><td>0.2</td><td>0.165872</td><td>0.875726</td></tr><tr><td>Identified values by GA</td><td>2135</td><td>0.182</td><td>0.171365</td><td>0.853471</td></tr><tr><td>Relative error of computing results for GA (%)<... | <table><tr><td></td><td>E/MPa</td><td>μ</td><td>α</td><td>K/MPa</td></tr><tr><td>Relative error of computing results for IGA (%)</td><td>0.65</td><td>6</td><td>1.17</td><td>2.41</td></tr></table> |
084c7534c7cd4e5cabc9061a5dddba6c51f1ccf289662293bb6764b32cd8543e.png | complex | <table><tr><td>TOOL</td><td colspan="6">COHORT CHARACTERISTICS</td></tr><tr><td> </td><td>Disease</td><td>Number</td><td>Age (years)</td><td>Time since diagnosis/transplant</td><td>Race & gender</td><td>Country of validation</td></tr><tr><td>TRAQ [4]</td><td>Chronic diseases</td><td>192</td><td>16-26 (mean: 19.7)</... | <table><tr><td>TOOL</td><td colspan="6">COHORT CHARACTERISTICS</td></tr></table> | <table><tr><td></td><td>Disease</td><td>Number</td><td>Age (years)</td><td>Time since diagnosis/transplant</td><td>Race & gender</td><td>Country of validation</td></tr><tr><td>TRAQ [4]</td><td>Chronic diseases</td><td>192</td><td>16-26 (mean: 19.7)</td><td>NR</td><td>64% white, 56% female</td><td>USA</td></tr><tr><td>U... |
fbcbde448d680a7d68352ef2dd7c6bec922a4fbdb6249c4998571a1c7c0fd98a.png | complex | <table><tr><td colspan="10">Phase II study</td></tr><tr><td rowspan="2">Patient</td><td rowspan="2">Treatment group</td><td colspan="8">Visit</td></tr><tr><td>BL</td><td>C2D1</td><td>C3D1</td><td>C4D1</td><td>D85</td><td>D180</td><td>D360</td><td>ET</td></tr><tr><td><i>1</i></td><td><i>Lipegfilgrastim</i></td><td><i>Ne... | <table><tr><td colspan="10">Phase II study</td></tr><tr><td rowspan="2">Patient</td><td rowspan="2">Treatment group</td><td colspan="8">Visit</td></tr><tr><td>BL</td><td>C2D1</td><td>C3D1</td><td>C4D1</td><td>D85</td><td>D180</td><td>D360</td><td>ET</td></tr><tr><td>1</td><td>Lipegfilgrastim</td><td>Neg</td><td>Neg</td... | <table><tr><td colspan="10">Phase II study</td></tr><tr><td rowspan="2">Patient</td><td rowspan="2">Treatment group</td><td colspan="8">Visit</td></tr><tr><td>BL</td><td>C2D1</td><td>C3D1</td><td>C4D1</td><td>D85</td><td>D180</td><td>D360</td><td>ET</td></tr><tr><td>18</td><td>Pegfilgrastim</td><td>NA</td><td>Pos</td><... |
6bdd9b5e161bbf04a34227f1215b45d2b05308acae181ec60c1c56fe7152a32b.png | complex | <table><tr><td rowspan="3">Birth Weight for Gestational Age</td><td colspan="6">Dietary Pattern</td></tr><tr><td>Cereals, Eggs, and Cantonese Soups</td><td>Dairy</td><td>Fruits, Nuts, and Cantonese Desserts</td><td>Meats</td><td>Vegetables</td><td>Varied</td></tr><tr><td>(<i>n</i> = 1026)</td><td>(<i>n</i> = 1020)</td>... | <table><tr><td rowspan="3">Birth Weight for Gestational Age</td><td colspan="6">Dietary Pattern</td></tr><tr><td>Cereals, Eggs, and Cantonese Soups</td><td>Dairy</td><td>Fruits, Nuts, and Cantonese Desserts</td><td>Meats</td><td>Vegetables</td><td>Varied</td></tr><tr><td>(n = 1026)</td><td>(n = 1020)</td><td>(n = 799)<... | <table><tr><td rowspan="3">Birth Weight for Gestational Age</td><td colspan="6">Dietary Pattern</td></tr><tr><td>Cereals, Eggs, and Cantonese Soups</td><td>Dairy</td><td>Fruits, Nuts, and Cantonese Desserts</td><td>Meats</td><td>Vegetables</td><td>Varied</td></tr><tr><td>(n = 1026)</td><td>(n = 1020)</td><td>(n = 799)<... |
f19782f1f8947e4c27ab993149e238697b050b5c8f4d61d51354213a55008b3e.png | complex | <table><tr><td rowspan="2">mRNA co-expression MET vs.</td><td colspan="2">ALL Stage</td><td colspan="2">Stage I-II</td><td colspan="2">Stage III-IV</td></tr><tr><td>Pearson's Correlation</td><td><i>p</i>-value</td><td>Pearson's Correlation</td><td><i>p</i>-value</td><td>Pearson's Correlation</td><td><i>p</i>-value</td>... | <table><tr><td rowspan="2">mRNA co-expression MET vs.</td><td colspan="2">ALL Stage</td><td colspan="2">Stage I-II</td><td colspan="2">Stage III-IV</td></tr><tr><td>Pearson's Correlation</td><td>p-value</td><td>Pearson's Correlation</td><td>p-value</td><td>Pearson's Correlation</td><td>p-value</td></tr><tr><td>ALDH1A1<... | <table><tr><td>CD133</td><td>0.30</td><td><0.001</td><td>0.31</td><td><0.001</td><td>0.40</td><td><0.001</td></tr><tr><td>KLF4</td><td>0.10</td><td><0.001</td><td>0.11</td><td><0.001</td><td>0.12</td><td>0.181</td></tr><tr><td>MYC</td><td>0.14</td><td><0.001</td><td>0.15</td><td><0.001</td><td>0.17</td><td>0.055</td></... |
f2c045feb4c0d601e6c9d8050f1ff9426cc921916c0c7812a586600fcf67c8b8.png | simple | <table><tr><td>Main objectives of participating in the training</td><td>n</td><td>%</td></tr><tr><td>To learn about psychosomatic medicine/biopsychosocial models</td><td>28</td><td>25%</td></tr><tr><td>To learn didactical teaching methods (such as interactive learning and presenting lectures)</td><td>23</td><td>20%</td... | <table><tr><td>Main objectives of participating in the training</td><td>n</td><td>%</td></tr><tr><td>To learn about psychosomatic medicine/biopsychosocial models</td><td>28</td><td>25%</td></tr><tr><td>To learn didactical teaching methods (such as interactive learning and presenting lectures)</td><td>23</td><td>20%</td... | <table><tr><td>Main objectives of participating in the training</td><td>n</td><td>%</td></tr><tr><td>To learn about the diagnosis and treatment of specific psychosomatic disorders</td><td>8</td><td>6%</td></tr><tr><td>To address administrative and sustainability issues in the curriculum</td><td>5</td><td>4%</td></tr><t... |
0be0175547bca70f32887bc3e8d2b2b1cfbaaf899818fed20c0ccb93d24ac648.png | complex | <table><tr><td></td><td colspan="2">Intervention, n = 114</td><td colspan="2">Comparison, n = 60</td></tr><tr><td>IPV status</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>0</td><td>9</td><td><i>8</i></td><td>6</td><td><i>10</i></td></tr><tr><td>3–6</td><td>11</td><td><i>10</i></td><td>2</td><td><i>3</i... | <table><tr><td></td><td colspan="2">Intervention, n = 114</td><td colspan="2">Comparison, n = 60</td></tr><tr><td>IPV status</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>0</td><td>9</td><td>8</td><td>6</td><td>10</td></tr><tr><td>3–6</td><td>11</td><td>10</td><td>2</td><td>3</td></tr><tr><td>≥ 7</td><td>93<... | <table><tr><td>≥ 7</td><td>76</td><td>95</td><td>39</td><td>95</td></tr><tr><td>Missing</td><td>0</td><td>0</td><td>1</td><td>2</td></tr><tr><td>Abused>12 months ago (n = 33)</td><td></td><td></td><td></td><td></td></tr><tr><td>0</td><td>4</td><td>20</td><td>3</td><td>23</td></tr><tr><td>3–6</td><td>3</td><td>15</td><t... |
331ec58ea2cdbe6921286757898d95b08b09570b1432d5ed4fc1f3b4600f3db5.png | complex | <table><tr><td>Item</td><td colspan="3">Patient Ratings</td><td colspan="3">Clinician Ratings</td></tr><tr><td></td><td>Localized</td><td>Metastatic</td><td>Total</td><td>Nurse</td><td>Physician</td><td>Total</td></tr><tr><td>PAIN</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I have pain</td><... | <table><tr><td>Item</td><td colspan="3">Patient Ratings</td><td colspan="3">Clinician Ratings</td></tr><tr><td></td><td>Localized</td><td>Metastatic</td><td>Total</td><td>Nurse</td><td>Physician</td><td>Total</td></tr><tr><td>PAIN</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>I have pain</td><t... | <table><tr><td>I am losing weight</td><td>1.4</td><td>2.0</td><td>1.7</td><td>3.5</td><td>3.6</td><td>3.6</td></tr><tr><td>COGNITIVE</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>I have difficulty remembering things</td><td>1.6</td><td>1.6</td><td>1.6</td><td>3.5</td><td>2.0</td><td>2.7</td></t... |
5e2d89443dfd3f10d94c97c629203b3367a12136f0d392c9e89f3a2b8a3e1e02.png | simple | <table><tr><td>Target genes</td><td>Primers</td></tr><tr><td>MMP1</td><td>Forward primer: 5′-aagccatcacttaccttgcact-3′</td></tr><tr><td></td><td>Reverse primer: 5′-tcagagaccttggtgaatgtca-3′</td></tr><tr><td>MMP9</td><td>Forward primer: 5′-ctggagacctgagaaccaa-3′</td></tr><tr><td></td>... | <table><tr><td>Target genes</td><td>Primers</td></tr><tr><td>MMP1</td><td>Forward primer: 5′-aagccatcacttaccttgcact-3′</td></tr></table> | <table><tr><td>Target genes</td><td>Primers</td></tr><tr><td></td><td>Reverse primer: 5′-tcagagaccttggtgaatgtca-3′</td></tr><tr><td>MMP9</td><td>Forward primer: 5′-ctggagacctgagaaccaa-3′</td></tr><tr><td></td><td>Reverse primer: 5′-actgctcaaagcctccacaaga-3′</td></tr><tr><td>β-Actin</td><td>Forward primer: 5′-ctccatcctg... |
0648fcfbd71405fb94fb090228756acf8dfcbd4342a0319a766b44f2cb11eaf0.png | complex | <table><tr><td rowspan="2">Metal</td><td colspan="2">SQGs (mg/kg)-Freshwater Sediment (Upstream)</td><td colspan="3">Percentage of Samples Exceeding SQGs (%)</td></tr><tr><td>TEL</td><td>PEL</td><td><TEL</td><td>TEL-PEL</td><td>>PEL</td></tr><tr><td>Cu</td><td>35.7</td><td>197</td><td>80.0</td><td>16.0</td><td>4.... | <table><tr><td rowspan="2">Metal</td><td colspan="2">SQGs (mg/kg)-Freshwater Sediment (Upstream)</td><td colspan="3">Percentage of Samples Exceeding SQGs (%)</td></tr><tr><td>TEL</td><td>PEL</td><td><TEL</td><td>TEL-PEL</td><td>>PEL</td></tr></table> | <table><tr><td>Cu</td><td>35.7</td><td>197</td><td>80.0</td><td>16.0</td><td>4.00</td></tr><tr><td>Zn</td><td>123</td><td>315</td><td>80.0</td><td>8.00</td><td>12.0</td></tr><tr><td>Cr</td><td>37.3</td><td>90.0</td><td>32.0</td><td>44.0</td><td>24.0</td></tr><tr><td>Ni</td><td>18.0</td><td>35.9</td><td>16.0</td><td>68.... |
3cf5cd8592533f8a4de912f0e011fac32465a9bbeedbb9eb5c3185796e6a935f.png | complex | <table><tr><td></td><td>Hue</td><td>Saturation</td><td>Value</td><td>Red</td><td>Green</td><td>Blue</td><td>Grey</td></tr><tr><td colspan="8">Low Resolution Normalised Images</td></tr><tr><td>Expert 1</td><td>90.8%</td><td>82.5%</td><td>85.8%</td><td>85.8%</td><td>87.0%</td><td>87.0%</td><td>90.8%</td></tr><tr><td>Expe... | <table><tr><td></td><td>Hue</td><td>Saturation</td><td>Value</td><td>Red</td><td>Green</td><td>Blue</td><td>Grey</td></tr><tr><td colspan="8">Low Resolution Normalised Images</td></tr><tr><td>Expert 1</td><td>90.8%</td><td>82.5%</td><td>85.8%</td><td>85.8%</td><td>87.0%</td><td>87.0%</td><td>90.8%</td></tr><tr><td>Expe... | <table><tr><td></td><td>Hue</td><td>Saturation</td><td>Value</td><td>Red</td><td>Green</td><td>Blue</td><td>Grey</td></tr><tr><td>xpert 3</td><td></td><td>0.3%</td><td>7.5%</td><td>5%</td><td></td><td>88.8%</td><td>%</td></tr><tr><td>Expert 4</td><td>91.8%</td><td>84.0%</td><td>84.3%</td><td>84.3%</td><td>86.0%</td><td... |
f8b0cbeb92fcfb014be783b3f8984cde54540e9019be0cf9ca7ebbb293f384c9.png | simple | <table><tr><td>Factor</td><td>Cronbach’s α</td><td>Item-to-subscale correlation</td><td>Subscale-to-total correlation</td></tr><tr><td>1 Psychological expression</td><td>0.92</td><td>0.58–0.75</td><td>0.92</td></tr><tr><td>2 Changes in self and family</td><td>0.82</td><td>0.49–0.62</td><td>0.73</... | <table><tr><td>Factor</td><td>Cronbach’s α</td><td>Item-to-subscale correlation</td><td>Subscale-to-total correlation</td></tr></table> | <table><tr><td>1 Psychological expression</td><td>0.92</td><td>0.58–0.75</td><td>0.92</td></tr><tr><td>2 Changes in self and family</td><td>0.82</td><td>0.49–0.62</td><td>0.73</td></tr><tr><td>3 Physical symptoms</td><td>0.81</td><td>0.31–0.64</td><td>0.80</td></tr><tr><td>4 Social and family connectedness</td><td>0.73... |
4e142f104ccfcfe908ba373cf59582dcba11c1b26ebdfade27cf918580132b90.png | simple | <table><tr><td></td><td>Transobturator Sling</td><td>Single-Incision Sling</td><td>p value</td></tr><tr><td>Preoperative daily pads usage (mean)</td><td>4.45±0.82 (3-6)</td><td>4.25±0.78 (3-6)</td><td>p=0.495</td></tr><tr><td>Postoperative daily pads usage (mean)</td><td>0.30±0.57 (0-2)</td><td>0.55±... | <table><tr><td></td><td>Transobturator Sling</td><td>Single-Incision Sling</td><td>p value</td></tr></table> | <table><tr><td>Preoperative daily pads usage (mean)</td><td>4.45±0.82 (3-6)</td><td>4.25±0.78 (3-6)</td><td>p=0.495</td></tr><tr><td>Postoperative daily pads usage (mean)</td><td>0.30±0.57 (0-2)</td><td>0.55±0,68 (0-2)</td><td>p=0.192</td></tr><tr><td>Postoperatively, the number of patients with</td><td>15 / 20</td><td... |
87273a619111f411ae5d5e41cb8b31f0fc06c8deaaad76a175281122a4c7d793.png | simple | <table><tr><td>Treatment options</td><td>Mean cost per child in A$2010-2011 (95%CI)</td><td>Mean number of QALYs (95%CI)</td><td>Mean incremental number of QALYs vs no treatment</td><td>ICER</td></tr><tr><td>No treatment</td><td>0</td><td>11.57</td><td>-</td><td>-</td></tr><tr><td></td><td></td><td>(10.24; 13.06)</td><... | <table><tr><td>Treatment options</td><td>Mean cost per child in A$2010-2011 (95%CI)</td><td>Mean number of QALYs (95%CI)</td><td>Mean incremental number of QALYs vs no treatment</td><td>ICER</td></tr><tr><td>No treatment</td><td>0</td><td>11.57</td><td>-</td><td>-</td></tr><tr><td></td><td></td><td>(10.24; 13.06)</td><... | <table><tr><td>counselling</td><td>25</td><td></td><td>1.02</td><td>83</td></tr><tr><td></td><td>(1927; 2335)</td><td>(11.62; 13.57)</td><td></td><td></td></tr><tr><td>TF-CBT only</td><td>2097</td><td>12.85</td><td>1.28</td><td>1638</td></tr><tr><td></td><td>(1904; 2302)</td><td>(11.98; 13.74)</td><td></td><td></td></t... |
f4f6864fac6d96462493e472b370f217a78fae6350edad5a76a932c07b32370f.png | complex | <table><tr><td></td><td>Total dust</td><td>Respirable crystalline silica dust</td></tr><tr><td colspan="3">Long-term average exposure (mg/m<sup>3</sup>)</td></tr><tr><td>Mean (SD)</td><td>6.1 (4.8)</td><td>0.27 (0.19)</td></tr><tr><td>Median (min.–max.)</td><td>4.8 (0–36.7)</td><td>0.22 (0–1.16)</td><... | <table><tr><td></td><td>Total dust</td><td>Respirable crystalline silica dust</td></tr><tr><td colspan="3">Long-term average exposure (mg/m3)</td></tr><tr><td>Mean (SD)</td><td>6.1 (4.8)</td><td>0.27 (0.19)</td></tr><tr><td>Median (min.–max.)</td><td>4.8 (0–36.7)</td><td>0.22 (0–1.16)</td></tr></table> | <table><tr><td></td><td>Total dust</td><td>Respirable crystalline silica dust</td></tr><tr><td colspan="3">Highest exposure ever* (mg/m3)</td></tr><tr><td>Mean (SD)</td><td>23.5 (11.6)</td><td>0.73 (0.34)</td></tr><tr><td>Median (min.–max.)</td><td>23.8 (0–65.8)</td><td>0.74 (0–1.95)</td></tr><tr><td colspan="3">Cumula... |
86a7497e5e02f10f56feb2b03a8cc5ca57c480ae3ac1b3b75ff0c9924c79d6eb.png | simple | <table><tr><td> </td><td>Qigong</td><td>Exercise therapy</td><td>Study population</td></tr><tr><td> </td><td>Mean (±SD)</td><td>Mean (±SD)</td><td>Mean (±SD)</td></tr><tr><td> </td><td><i>N</i> = 10 8 female, 2 male</td><td><i>N</i> = 10 8 female, 2 male</td><td><i>N</i> = 122 107 female, 25 male</td></t... | <table><tr><td></td><td>Qigong</td><td>Exercise therapy</td></tr><tr><td></td><td>Mean (±SD)</td><td>Mean (±SD)</td></tr><tr><td></td><td>N = 10 8 female, 2 male</td><td>N = 10 8 female, 2 male</td></tr><tr><td>Age (years)</td><td>40.6 (±10.3)</td><td>44.6 (±9.3)</td></tr><tr><td>VAS baseline (mm)</td><td>60.1 (±13.1)<... | <table><tr><td>Study population</td></tr><tr><td>Mean (±SD)</td></tr><tr><td>N = 122 107 female, 25 male</td></tr><tr><td>45.6 (±10.7)</td></tr><tr><td>56.2 (±14.1)</td></tr><tr><td>3.2 (±1.6)</td></tr></table> |
3057f875a42ffd8f16480aefc9af48e00479d5fb02364549b7624b6acf303ec6.png | complex | <table><tr><td rowspan="2">Stage</td><td colspan="2">OS</td></tr><tr><td>HR(95% CI)</td><td>P-value<sup>‡</sup></td></tr><tr><td>T2</td><td></td><td></td></tr><tr><td> RT+Surg Vs Surg</td><td>1.085(0.745-1.581)</td><td>0.671</td></tr><tr><td> Surg+RT Vs Surg</td><td>0.776(0.400-1.507)</td><td>0.454</td></tr><tr><... | <table><tr><td rowspan="2">Stage</td><td colspan="2">OS</td></tr><tr><td>HR(95% CI)</td><td>P-value‡</td></tr><tr><td>T2</td><td></td><td></td></tr></table> | <table><tr><td rowspan="2">Stage</td><td colspan="2">OS</td></tr><tr><td>HR(95% CI)</td><td>P-value‡</td></tr><tr><td>RT+Surg Vs Surg</td><td>1.085(0.745-1.581)</td><td>0.671</td></tr><tr><td>Surg+RT Vs Surg</td><td>0.776(0.400-1.507)</td><td>0.454</td></tr><tr><td>T3</td><td></td><td></td></tr><tr><td>RT+Surg Vs Surg<... |
a0917c19192b0c2d99ff77b178df953c81a27254d6d962644764b1da962877fc.png | simple | <table><tr><td>General descriptives</td><td>∑ Tot.</td><td>Sand</td><td>Canopy-forming algae</td><td>Seagrass aboveground</td><td>Seagrass belowground</td></tr><tr><td><i>Traditional numerical variables</i></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td># of species </td><td>36</td><td>17</td><td>2... | <table><tr><td>General descriptives</td><td>∑ Tot.</td><td>Sand</td><td>Canopy-forming algae</td><td>Seagrass aboveground</td><td>Seagrass belowground</td></tr><tr><td>Traditional numerical variables</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td># of species</td><td>36</td><td>17</td><td>26</td><td>29</... | <table><tr><td>General descriptives</td><td>∑ Tot.</td><td>Sand</td><td>Canopy-forming algae</td><td>Seagrass aboveground</td><td>Seagrass belowground</td></tr><tr><td>al variables</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td># of modalities expressed (Total)</td><td>55</td><td>51</td><td>55</td><td>54... |
1ca9bc188f7fab99cd22846dc4e259585f82c1d63e72dd1d45438ba33ca3124a.png | complex | <table><tr><td> </td><td colspan="2">Shift admitted</td><td rowspan="2"><i>p</i> value</td></tr><tr><td> </td><td>Day</td><td>Night</td></tr><tr><td>Mortality (%)</td><td>3.5</td><td>4.3</td><td>0.57</td></tr><tr><td>ICU admission (%)</td><td>2.2</td><td>3.2</td><td>0.32</td></tr><tr><td>Mean length of stay (days)</td>... | <table><tr><td></td><td>Shift admitted</td></tr><tr><td></td><td>Day</td></tr><tr><td>Mortality (%)</td><td>3.5</td></tr><tr><td>ICU admission (%)</td><td>2.2</td></tr><tr><td>Mean length of stay (days)</td><td>5.1</td></tr><tr><td>Readmission, 30 days (%)</td><td>8.1</td></tr><tr><td>Need for surgery (%)</td><td>43.5<... | <table><tr><td>Shift admitted</td><td rowspan="2">p value</td></tr><tr><td>Night</td></tr><tr><td>4.3</td><td>0.57</td></tr><tr><td>3.2</td><td>0.32</td></tr><tr><td>5.7</td><td>0.18∗</td></tr><tr><td>7.1</td><td>0.60</td></tr><tr><td>39.6</td><td>0.26</td></tr></table> |
8dec3eb22597635e108f62179161fef2290b1da61d6217d498e924670ce965c2.png | complex | <table><tr><td></td><td></td><td></td><td colspan="7">Bivariate Correlations</td></tr><tr><td></td><td><i>M</i></td><td><i>SD</i></td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td></tr><tr><td>DERS total</td><td>83.76</td><td>25.80</td><td>_</td><td></td><td></td><td></td><td></td><td></td><td><... | <table><tr><td></td><td></td><td></td><td colspan="7">Bivariate Correlations</td></tr></table> | <table><tr><td></td><td>M</td><td>SD</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td></tr><tr><td>DERS total</td><td>83.76</td><td>25.80</td><td>_</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>DBT Skills Use</td><td>1.92</td><td>.40</td><td>-.36**</td><td>_</td><td></t... |
7e3837f30f1d4ebcbfd79845f283e0e2d835a23602f2c89e708c65e1de39fb9a.png | complex | <table><tr><td></td><td colspan="3">Knowledge</td><td colspan="3">Tick check frequency</td></tr><tr><td></td><td>β</td><td>S.E.</td><td><i>p</i>value</td><td>β<sup>a</sup></td><td>S.E.</td><td><i>p</i>value</td></tr><tr><td>(Intercept)</td><td>0.522</td><td>0.265</td><td>0.049</td><td>−0.034</td><td>0.2... | <table><tr><td></td><td colspan="3">Knowledge</td><td colspan="3">Tick check frequency</td></tr><tr><td></td><td>β</td><td>S.E.</td><td>pvalue</td><td>βa</td><td>S.E.</td><td>pvalue</td></tr><tr><td>(Intercept)</td><td>0.522</td><td>0.265</td><td>0.049</td><td>−0.034</td><td>0.241</td><td>0.886</td></tr><tr><td>t2 (ref... | <table><tr><td>Having had lectures on ticks</td><td>0.535</td><td>0.184</td><td>0.004</td><td>0.215</td><td>0.176</td><td>0.222</td></tr><tr><td>t2aLeaflet</td><td>0.735</td><td>0.409</td><td>0.072</td><td>−0.601</td><td>0.291</td><td>0.039</td></tr><tr><td>t2aControl</td><td>−0.532</td><td>0.335</td><td>0.112</td><td>... |
4ac955a1270cbdc606749bf5e15a83fc8ddd88da4e574a0c93aca6046e736af9.png | complex | <table><tr><td>Haplotype</td><td colspan="2">Honduras (n = 77)</td><td colspan="2">Nicaragua (n = 33)</td></tr><tr><td> </td><td>Number of samples</td><td>Frequency</td><td>Number of samples</td><td>Frequency</td></tr><tr><td>I</td><td>22</td><td>0.29</td><td>9</td><td>0.27</td></tr><tr><td>II</td><td>2</td><td>0.03</t... | <table><tr><td>Haplotype</td><td colspan="2">Honduras (n = 77)</td><td colspan="2">Nicaragua (n = 33)</td></tr><tr><td></td><td>Number of samples</td><td>Frequency</td><td>Number of samples</td><td>Frequency</td></tr><tr><td>I</td><td>22</td><td>0.29</td><td>9</td><td>0.27</td></tr><tr><td>II</td><td>2</td><td>0.03</td... | <table><tr><td>XVIII</td><td>6</td><td>0.08</td><td>0</td><td>0</td></tr><tr><td>XIX</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XX</td><td>2</td><td>0.03</td><td>0</td><td>0</td></tr><tr><td>XXI</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XXII</td><td>1</td><td>0.01</td><td>0</td><td>0<... |
fa9c01f387cb2635d5eba414b4d664b59867405bf2c9158fa0b4df7f3018e139.png | simple | <table><tr><td>Origin</td><td>Region</td><td>Isolate serial number</td><td>Total number of isolates</td><td>Number of genotypes</td><td>Number of polymorphic loci</td><td>Polymorphic loci (%)</td></tr><tr><td>Rich Kser Wallal</td><td>Rich Errachidia</td><td>7</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Ric... | <table><tr><td>Origin</td><td>Region</td><td>Isolate serial number</td><td>Total number of isolates</td><td>Number of genotypes</td><td>Number of polymorphic loci</td><td>Polymorphic loci (%)</td></tr><tr><td>Rich Kser Wallal</td><td>Rich Errachidia</td><td>7</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Ric... | <table><tr><td>Ziz Errachidia</td><td>Ziz</td><td>122</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Over all</td><td>-</td><td>-</td><td>21</td><td>21</td><td>35</td><td>94.59</td></tr></table> |
283c0bb6afe6e6e47cac5550a8a8e4434c51f6c954dd550b4be39b213f56a85e.png | simple | <table><tr><td> </td><td>1st set</td><td>1st set CV</td><td>2nd set</td><td>2st set CV</td><td>SDw</td><td>CV (%)</td><td>ICC</td></tr><tr><td>Rrs5 (kPa/L/sec)</td><td>1.11 ± 0.24</td><td>8.04 ± 11.9</td><td>1.10 ± 0.18</td><td>7.68 ± 4.0</td><td>0.37</td><td>4.64</td><td>0.88 (0.76–0.94)</td>... | <table><tr><td></td><td>1st set</td><td>1st set CV</td><td>2nd set</td><td>2st set CV</td><td>SDw</td><td>CV (%)</td><td>ICC</td></tr><tr><td></td><td>1.11 ± 0</td><td>8.0</td><td></td><td></td><td>0.37</td><td>4.64</td><td>0.88 (0.76–0.94</td></tr></table> | <table><tr><td></td><td>1st set</td><td>1st set CV</td><td>2nd set</td><td>2st set CV</td><td>SDw</td><td>CV (%)</td><td>ICC</td></tr><tr><td>Rrs5 (kPa/L/sec)</td><td>.24</td><td>4 ± 11.9</td><td>1.10 ± 0.18</td><td>7.68 ± 4.0</td><td></td><td></td><td>)</td></tr><tr><td>Rrs10 (kPa/L/sec)</td><td>0.90 ± 0.17</td><td>5.... |
a40041c9515bd29fb010191b42395d5f99a9c23a4e5dd016272081c234d5f8ca.png | complex | <table><tr><td>HCC parameters</td><td>Number of patients</td><td>miR-940 (−)</td><td>miR-940 (+)</td><td><i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Male</td><td>38</td><td>31</td><td>7</td><td rowspan="2">0.515</td><td row... | <table><tr><td>HCC parameters</td><td>Number of patients</td><td>miR-940 (−)</td><td>miR-940 (+)</td><td>χ2</td><td>P</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>38</td><td>31</td><td>7</td><td rowspan="2">0.515</td><td rowspan="2">0.473</td></tr><tr><td>Female</td... | <table><tr><td>Age</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>≥50 years old</td><td>36</td><td>29</td><td>7</td><td rowspan="2">0.080</td><td rowspan="2">0.777</td></tr><tr><td><50 years old</td><td>10</td><td>7</td><td>3</td></tr><tr><td>Etiology</td><td></td><td></td><td></td><td></td><td></td></tr... |
542d0003d337c533a10b8ed9d0c5b0cddbc3b4ccc0be5b0f9aeb6932ff70ef28.png | simple | <table><tr><td>Target protein or pathway</td><td>Drug</td><td>CHIKV IC<sub>50</sub> (μM)</td><td>WST-1 IC<sub>50</sub> (μM)</td><td>Therapeutic index</td></tr><tr><td>Fatty acid synthesis</td><td>TOFA</td><td>0.15</td><td>> 60*</td><td>NT</td></tr><tr><td> </td><td>Orlistat</td><td>0.82</td><td>8.67</td><t... | <table><tr><td>Target protein or pathway</td><td>Drug</td><td>CHIKV IC50 (μM)</td><td>WST-1 IC50 (μM)</td><td>Therapeutic index</td></tr><tr><td>Fatty acid synthesis</td><td>TOFA</td><td>0.15</td><td>> 60*</td><td>NT</td></tr><tr><td></td><td>Orlistat</td><td>0.82</td><td>8.67</td><td>10.57</td></tr><tr><td></td><td>Ce... | <table><tr><td>Target protein or pathway</td><td>Drug</td><td>CHIKV IC50 (μM)</td><td>WST-1 IC50 (μM)</td><td>Therapeutic index</td></tr><tr><td></td><td>Prenylamine</td><td>2.39</td><td>16.53</td><td>6.91</td></tr><tr><td></td><td>Felodipine</td><td>3.24</td><td>12.08</td><td>3.73</td></tr><tr><td>FLT4</td><td>Alsterp... |
a2c59155f139f52f26df26f664df45179cf13d431a93c78c82bd45e3c47725a5.png | simple | <table><tr><td>Country</td><td>Year</td><td>Sample size</td><td>Age range</td><td>Both genders</td><td>Male</td><td>Female</td></tr><tr><td>Southern China</td><td>2008</td><td>446</td><td>55</td><td>19.1%</td><td>14.5%</td><td>24.4%</td></tr><tr><td>Taiwan [10]</td><td>2000</td><td>1937</td><td>65+</td><td>32.5%</td><t... | <table><tr><td>Country</td><td>Year</td><td>Sample size</td><td>Age range</td></tr><tr><td>Southern China</td><td>2008</td><td>446</td><td>55</td></tr><tr><td>Taiwan [10]</td><td>2000</td><td>1937</td><td>65+</td></tr><tr><td>Japan [11]</td><td>2006</td><td>572</td><td>55-75</td></tr><tr><td>Australia [12]</td><td>2001... | <table><tr><td>Both genders</td><td>Male</td><td>Female</td></tr><tr><td>19.1%</td><td>14.5%</td><td>24.4%</td></tr><tr><td>32.5%</td><td>30.1%</td><td>34.9%</td></tr><tr><td>45.8%</td><td>41.7%</td><td>52.5%</td></tr><tr><td>43%</td><td>35%</td><td>52%</td></tr><tr><td>36.1%</td><td>24.7%</td><td>43.7%</td></tr><tr><t... |
f2bca81ba9afac2b18b04121b5e66979437c6d65e3bd42cc2fae164f4925d5ea.png | simple | <table><tr><td>Name BRE</td><td>5′ primer (5′-3′)</td><td>3′ primer (5′-3′)</td><td>size (bp)</td></tr><tr><td>7–13</td><td>GATGAGCTCATGCGAAAGTGAAGGTGGTCCCCAG</td><td>TGAAGATCTAGCAAGGAGGAACTGGAGATGTCA</td><td>1278</td></tr><tr><td>9–13</td><td>GAGCTCTCGAACCTCTCTTTCCTATCTC... | <table><tr><td>Name BRE</td></tr><tr><td>7–13</td></tr><tr><td>9–13</td></tr><tr><td>10–13</td></tr><tr><td>12–13</td></tr><tr><td>9</td></tr><tr><td>9–10</td></tr><tr><td>9–11</td></tr></table> | <table><tr><td>5′ primer (5′-3′)</td><td>3′ primer (5′-3′)</td><td>size (bp)</td></tr><tr><td>GATGAGCTCATGCGAAAGTGAAGGTGGTCCCCAG</td><td>TGAAGATCTAGCAAGGAGGAACTGGAGATGTCA</td><td>1278</td></tr><tr><td>GAGCTCTCGAACCTCTCTTTCCTATCTC</td><td>AGATCTAGCAAGGAGGAACTGGAGATGTCA</td><td>695</td></tr><tr><td>GAGCTCTGGAGCTGAGCCTGGA... |
c0abab8f54c68f201176ce26c58c54d6cc21f21b90e272915d3a84cc8d2e7929.png | simple | <table><tr><td>Age (years)</td><td>Male [positive/total (%)]</td><td>Female [positive/total (%)]</td><td>Total [positive/total (%)]</td></tr><tr><td>17-27</td><td>7/452 (1.54)</td><td>10/585 (1.7)</td><td>17/1037 (1.63)</td></tr><tr><td>28-36</td><td>4/326 (1.22)</td><td>7/365 (1.91)</td><td>11/691 (1.59)</td></tr><tr>... | <table><tr><td>Age (years)</td><td>Male [positive/total (%)]</td><td>Female [positive/total (%)]</td><td>Total [positive/total (%)]</td></tr><tr><td>17-27</td><td>7/452 (1.54)</td><td>10/585 (1.7)</td><td>17/1037 (1.63)</td></tr><tr><td>28-36</td><td>4/326 (1.22)</td><td>7/365 (1.91)</td><td>11/691 (1.59)</td></tr></ta... | <table><tr><td>Age (years)</td><td>Male [positive/total (%)]</td><td>Female [positive/total (%)]</td><td>Total [positive/total (%)]</td></tr><tr><td>37-53</td><td>6/137 (4.37)</td><td>8/293 (2.73)</td><td>14/430 (3.25)</td></tr><tr><td>54-79</td><td>5/180 (2.77)</td><td>5/350 (1.42)</td><td>10/530 (1.88)</td></tr><tr><... |
d15d2831b523652439349c196dceb12a5e384fe078aab52302472d3730a89276.png | simple | <table><tr><td>Characteristics</td><td>PA group (<i>N</i> = 145)</td><td>Non-PA group (<i>N</i> = 79)</td><td><i>P</i> value</td></tr><tr><td>Age, years (mean ± SD)</td><td>67.6 ± 11.7</td><td>65.0 ± 12.6</td><td>0.128</td></tr><tr><td>Sex (male/female)</td><td>94 (64.8%)/51 (35.2%)</td><td>54 (68.4%)/25... | <table><tr><td>Characteristics</td><td>PA group (N = 145)</td><td>Non-PA group (N = 79)</td><td>P value</td></tr><tr><td>Age, years (mean ± SD)</td><td>67.6 ± 11.7</td><td>65.0 ± 12.6</td><td>0.128</td></tr><tr><td>Sex (male/female)</td><td>94 (64.8%)/51 (35.2%)</td><td>54 (68.4%)/25 (31.6%)</td><td>0.659</td></tr><tr>... | <table><tr><td>Degree of obstruction (total/subtotal)</td><td>42 (29.0%)/103 (71.0%)</td><td>19 (24.1%)/60 (75.9%)</td><td>0.530</td></tr><tr><td>Mechanical ileus∗</td><td>80 (55.2%)</td><td>24 (27.8%)</td><td><0.001</td></tr><tr><td>Carcinomatosis peritonei</td><td>18 (12.4%)</td><td>7 (8.9%)</td><td>0.509</td></tr><t... |
64bc28821b94914e887cb426d37ec475df6ce03a56f85738eb41c596f6754a0f.png | complex | <table><tr><td>Outcomes</td><td>Group</td><td>LS mean ± SE<sup>a</sup></td><td>Difference<sup>b</sup> (95 % CI)</td><td><i>P</i>-value</td></tr><tr><td colspan="5">Primary outcome</td></tr><tr><td colspan="5"> Total VSCs</td></tr><tr><td rowspan="2">10 min</td><td>Test</td><td>0.115 ± 0.078</td><td>−0.2... | <table><tr><td>Outcomes</td><td>Group</td><td>LS mean ± SEa</td><td>Differenceb (95 % CI)</td><td>P-value</td></tr><tr><td colspan="5">Primary outcome</td></tr><tr><td colspan="5">Total VSCs</td></tr><tr><td rowspan="2">10 min</td><td>Test</td><td>0.115 ± 0.078</td><td>−0.246</td><td rowspan="2">0.002</td></tr><tr><td>... | <table><tr><td>Outcomes</td><td>Group</td><td>LS mean ± SEa</td><td>Differenceb (95 % CI)</td><td>P-value</td></tr><tr><td></td><td>ebo</td><td>9 ± 0.090</td><td></td><td>99</td></tr><tr><td colspan="5">Secondary outcomes</td></tr><tr><td colspan="5">H2S</td></tr><tr><td rowspan="2">10 min</td><td>Test</td><td>−0.085 ±... |
b8de75b48e892672b3916de50cdc5896345c87048443f040ff624f66e88f9937.png | complex | <table><tr><td>Dependent variable</td><td>Independent variable</td><td>Estimate</td><td>Standard error</td><td>95% CI</td><td><i>P</i></td></tr><tr><td rowspan="4">SF-BP</td><td>Migraine (yes vs. no)</td><td>−8.93</td><td>1.40</td><td>−6.20 to −11.67</td><td><0.001</td></tr><tr><td>HAMD (one-point ... | <table><tr><td>Dependent variable</td><td>Independent variable</td><td>Estimate</td><td>Standard error</td><td>95% CI</td><td>P</td></tr><tr><td rowspan="2">SF-BP</td><td>Migraine (yes vs. no)</td><td>−8.93</td><td>1.40</td><td>−6.20 to −11.67</td><td><0.001</td></tr><tr><td>HAMD (one-point increment)</td><td>−1.20</td... | <table><tr><td rowspan="2">SF-BP</td><td>HADS-A (one-point increment)</td><td>−0.59</td><td>0.19</td><td>−0.22 to −0.96</td><td><0.01</td></tr><tr><td>Educational years (one-year increment)</td><td>0.90</td><td>0.29</td><td>1.47 to 0.32</td><td><0.01</td></tr><tr><td rowspan="7">PS</td><td>Migraine (yes vs. no)</td><td... |
0ae8713bf8f50b03cf94637bda1d22a94b5009ede302c31fed83098dbcb179e6.png | complex | <table><tr><td rowspan="2">Coal samples</td><td colspan="4">Atomic concentration of elements/%</td><td colspan="2">(O/C) ratio/%</td></tr><tr><td>C 1s</td><td>O 1s</td><td>N 1s</td><td>S 2p</td><td>Elemental analysis</td><td>XPS analysis</td></tr><tr><td>Beizao lignite</td><td>80.34</td><td>18.22</td><td>1.44</td><td>/... | <table><tr><td rowspan="2">Coal samples</td><td colspan="4">Atomic concentration of elements/%</td><td colspan="2">(O/C) ratio/%</td></tr><tr><td>C 1s</td><td>O 1s</td><td>N 1s</td><td>S 2p</td><td>Elemental analysis</td><td>XPS analysis</td></tr><tr><td>Beizao lignite</td><td>80.34</td><td>18.22</td><td>1.44</td><td>/... | <table><tr><td rowspan="2">Coal samples</td><td colspan="4">Atomic concentration of elements/%</td><td colspan="2">(O/C) ratio/%</td></tr><tr><td>C 1s</td><td>O 1s</td><td>N 1s</td><td>S 2p</td><td>Elemental analysis</td><td>XPS analysis</td></tr><tr><td>Daliuta long flame coal</td><td>84.37</td><td>14.17</td><td>0.94<... |
5f3af768bbf1c34e534d5b8238e53d892caf406b32903d034e53d8b3e9369a3d.png | simple | <table><tr><td>Variable</td><td>N</td><td>R Pearson Correlation</td><td>Level of significance</td></tr><tr><td>Organizational culture and organizational commitment</td><td>165</td><td>0.419</td><td>0.027</td></tr></table> | <table><tr><td>Variable</td><td>N</td><td>R Pearson Correlation</td><td>Level of significance</td></tr></table> | <table><tr><td>Organizational culture and organizational commitment</td><td>165</td><td>0.419</td><td>0.027</td></tr></table> |
4fc091c5306b84d46f985a610ca757d681847e014a63ab91a6c99e4505e4d451.png | complex | <table><tr><td>Variable</td><td><i>b</i></td><td>Wald</td><td>OR</td><td>95% CI for OR</td></tr><tr><td>Unreasonable illegitimate Tasks</td><td>0.53*</td><td>6.69</td><td>1.69</td><td>[1.14–2.52]</td></tr><tr><td>Role Conflict</td><td>0.08</td><td>0.33</td><td>1.08</td><td>[0.83–1.40]</td></tr><tr><td>Contr... | <table><tr><td>Variable</td><td>b</td></tr><tr><td>Unreasonable illegitimate Tasks</td><td>0.53*</td></tr><tr><td>Role Conflict</td><td>0.08</td></tr><tr><td>Control over Work Pace</td><td>−0.44**</td></tr><tr><td>Exhaustion</td><td>0.59**</td></tr><tr><td>Administrative Tasks</td><td>0.004</td></tr><tr><td>Gender</td>... | <table><tr><td>Wald</td><td>OR</td><td>95% CI for OR</td></tr><tr><td>6.69</td><td>1.69</td><td>[1.14–2.52]</td></tr><tr><td>0.33</td><td>1.08</td><td>[0.83–1.40]</td></tr><tr><td>15.48</td><td>.64</td><td>[0.52–0.80]</td></tr><tr><td>11.24</td><td>1.81</td><td>[1.28–2.55]</td></tr><tr><td>0.55</td><td>1.00</td><td>[0.... |
eef7a9f43a6580a735c4f990951b12c8f14a07f36cc7d3bc9a35d18104838cca.png | simple | <table><tr><td>RSV</td><td>Influenza A (H1N1) virus</td></tr><tr><td>Age <6 months</td><td>Age <5 years</td></tr><tr><td>History of prematurity</td><td>Chronic lung disease</td></tr><tr><td>Chronic lung disease</td><td>Congenital heart disease</td></tr><tr><td>Congenital heart disease</td><td>Immunocompromised co... | <table><tr><td>RSV</td><td>Influenza A (H1N1) virus</td></tr><tr><td>Age <6 months</td><td>Age <5 years</td></tr></table> | <table><tr><td>History of prematurity</td><td>Chronic lung disease</td></tr><tr><td>Chronic lung disease</td><td>Congenital heart disease</td></tr><tr><td>Congenital heart disease</td><td>Immunocompromised conditions</td></tr><tr><td>Viral coinfection</td><td></td></tr></table> |
bd20983cb54b176880e92b35d650c6996de964660186746ad436ca0f57ecd565.png | simple | <table><tr><td>Group</td><td>Sub group</td><td>Gender</td><td>Age (years ± <i>SD</i>)</td><td>Verbal memory (score ± <i>SD</i>)</td><td>O&M (years ± <i>SD</i>)</td></tr><tr><td>Gamers</td><td>Early blind</td><td>4 m/4 f</td><td>24.00 ± 6.76</td><td>81.13 ± 15.29</td><td>14.25 ± 7.78</t... | <table><tr><td>Group</td><td>Sub group</td><td>Gender</td><td>Age (years ± SD)</td><td>Verbal memory (score ± SD)</td><td>O&M (years ± SD)</td></tr><tr><td>Gamers</td><td>Early blind</td><td>4 m/4 f</td><td>24.00 ± 6.76</td><td>81.13 ± 15.29</td><td>14.25 ± 7.78</td></tr><tr><td></td><td>Late blind</td><td>5 m/2 f</td>... | <table><tr><td>Group</td><td>Sub group</td><td>Gender</td><td>Age (years ± SD)</td><td>Verbal memory (score ± SD)</td><td>O&M (years ± SD)</td></tr><tr><td></td><td>Late blind</td><td>4 m/3 f</td><td>31.71 ± 10.45</td><td>83.43 ± 11.49</td><td>1.0 ± 0.00*</td></tr><tr><td></td><td>Subgroup totals/means</td><td>8 m/6 f<... |
4101273cf350b59b81f6c4c9777f8b9567a268e9fdccb4d1ccecbfac58b61131.png | simple | <table><tr><td>Sensory neurons in the DRGs</td><td>BL40</td><td>GB30</td></tr><tr><td>Large-sized neuron</td><td>58 (10.78%)</td><td>149 (17.21%)</td></tr><tr><td>Medium-sized neuron</td><td>222 (41.26%)</td><td>357 (41.22%)</td></tr><tr><td>Small-sized neuron</td><td>258 (47.96%)</td><td>360 (41.57%)</td></tr></table> | <table><tr><td>Sensory neurons in the DRGs</td><td>BL40</td><td>GB30</td></tr></table> | <table><tr><td>Large-sized neuron</td><td>58 (10.78%)</td><td>149 (17.21%)</td></tr><tr><td>Medium-sized neuron</td><td>222 (41.26%)</td><td>357 (41.22%)</td></tr><tr><td>Small-sized neuron</td><td>258 (47.96%)</td><td>360 (41.57%)</td></tr></table> |
ffe1a52e30bc528287824da9c1e9034196659d9b7e62382eaefad754e44d0e31.png | complex | <table><tr><td></td><td></td><td>Number</td><td>Percent</td></tr><tr><td rowspan="2">Gender</td><td>Female</td><td>379</td><td>90.9</td></tr><tr><td>Male</td><td>38</td><td>9.1</td></tr><tr><td rowspan="2">Country</td><td>Australia</td><td>396</td><td>94.9</td></tr><tr><td>New Zealand</td><td>21</td><td>5.1</td></tr><t... | <table><tr><td></td><td></td><td>Number</td><td>Percent</td></tr><tr><td rowspan="2">Gender</td><td>Female</td><td>379</td><td>90.9</td></tr><tr><td>Male</td><td>38</td><td>9.1</td></tr><tr><td rowspan="2">Country</td><td>Australia</td><td>396</td><td>94.9</td></tr><tr><td>New Zealand</td><td>21</td><td>5.1</td></tr><t... | <table><tr><td></td><td></td><td>Number</td><td>Percent</td></tr><tr><td rowspan="3">Length of Time Working in Haemodialysis</td><td>11-15 years</td><td>94</td><td>22.5</td></tr><tr><td>16-20 years</td><td>41</td><td>9.8</td></tr><tr><td>>20 years</td><td>63</td><td>15.1</td></tr><tr><td rowspan="2">Nursing Classificat... |
24bcffdcf4cfffb17ae99b3c57d6b8c21a1c0121a23ba048f8e6e5d02ee0a58f.png | simple | <table><tr><td>Inclusion criteria</td><td>Exclusion criteria</td></tr><tr><td>Women < 40 years old</td><td>Women who conceived the fetus using artificial methods including in-vitro fertilization or intrauterine insemination</td></tr><tr><td>Aboriginal ancestry</td><td>Women carrying more than one fetus</td></tr><tr>... | <table><tr><td>Inclusion criteria</td><td>Exclusion criteria</td></tr></table> | <table><tr><td>Women < 40 years old</td><td>Women who conceived the fetus using artificial methods including in-vitro fertilization or intrauterine insemination</td></tr><tr><td>Aboriginal ancestry</td><td>Women carrying more than one fetus</td></tr><tr><td>Pregnant with singleton</td><td>Surrogate mothers</td></tr><tr... |
2e441c929de02b2c3166a45d220bd89e0c380af606344ffe2dd31974f5b2da7b.png | simple | <table><tr><td>Variable</td><td>Points</td></tr><tr><td>Age >80 years</td><td>1</td></tr><tr><td>History of cancer</td><td>1</td></tr><tr><td>History of heart failure or chronic lung disease</td><td>1</td></tr><tr><td>Pulse rate ≥110 bpm</td><td>1</td></tr><tr><td>Systolic blood pressure <100 mmHg</td><td>1... | <table><tr><td>Variable</td><td>Points</td></tr></table> | <table><tr><td>Age >80 years</td><td>1</td></tr><tr><td>History of cancer</td><td>1</td></tr><tr><td>History of heart failure or chronic lung disease</td><td>1</td></tr><tr><td>Pulse rate ≥110 bpm</td><td>1</td></tr><tr><td>Systolic blood pressure <100 mmHg</td><td>1</td></tr><tr><td>Oxygen saturation <90 % on room air... |
45643286bbe872e3abf36a1d5e65435d2fee1d1aaf115ca863ee9a2378207c74.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">Knowledgeable</td><td rowspan="2">COR 95 % CI</td><td rowspan="2">AOR 95 % CI</td></tr><tr><td>Yes</td><td>No</td></tr><tr><td colspan="5">Sex</td></tr><tr><td> Male</td><td>229</td><td>281</td><td>2.07 (1.55, 2.78)</td><td>1.89 (1.36, 2.61)**</td></tr><tr><td> F... | <table><tr><td rowspan="2">Variables</td><td colspan="2">Knowledgeable</td><td rowspan="2">COR 95 % CI</td><td rowspan="2">AOR 95 % CI</td></tr><tr><td>Yes</td><td>No</td></tr><tr><td colspan="5">Sex</td></tr><tr><td>Male</td><td>229</td><td>281</td><td>2.07 (1.55, 2.78)</td><td>1.89 (1.36, 2.61)**</td></tr><tr><td>Fem... | <table><tr><td>> 45</td><td>31</td><td>84</td><td>1</td><td>1</td></tr><tr><td colspan="5">Educational status</td></tr><tr><td>Non formal education</td><td>18</td><td>84</td><td>1</td><td>1</td></tr><tr><td>Primary school (1–8th)</td><td>30</td><td>36</td><td>3.89 (1.93, 7.85)</td><td>2.93 (1.39, 6.17)*</td></tr><tr><t... |
e8c7f458ee9bf0f5f4e0b76ab30972f906ba6b720a2fe6b01c49a3c50047de61.png | complex | <table><tr><td></td><td colspan="4">Geometric mean</td><td colspan="4">95th percentile</td></tr><tr><td></td><td colspan="2">DEP</td><td colspan="2">DEHP</td><td colspan="2">DEP</td><td colspan="2">DEHP</td></tr><tr><td>Population group</td><td>MEP</td><td>MEHP</td><td>MEHHP</td><td>MEOHP</td><td>MEP</td><td>MEHP</td><... | <table><tr><td></td><td>Geometric mean</td></tr><tr><td></td><td>DEP</td></tr><tr><td>Population group</td><td>MEP</td></tr><tr><td>289 adults (Blount et al. 2000b)</td><td>345 (11.4)</td></tr><tr><td>2,536 persons 6 to > 20 years of age (Silva et al. 2004a)</td><td>163 (5.4)</td></tr><tr><td>2,772 persons 6 to > 20 ye... | <table><tr><td colspan="3">Geometric mean</td><td colspan="4">95th percentile</td></tr><tr><td>DEP</td><td colspan="2">DEHP</td><td colspan="2">DEP</td><td colspan="2">DEHP</td></tr><tr><td>MEHP</td><td>MEHHP</td><td>MEOHP</td><td>MEP</td><td>MEHP</td><td>MEHHP</td><td>MEOHP</td></tr><tr><td>3.0 (0.5)</td><td>ND</td><t... |
25bfb72d519b2b83aa58dd811a48e17270d8663a1917b1eb8804f2acce983ea7.png | simple | <table><tr><td></td><td>Description of framework objectives</td></tr><tr><td>1.</td><td>Surveillance to develop shared operational definitions and determinants of mental illness</td></tr><tr><td>2.</td><td>Epidemiological research into determinants and protective factors for mental health and their relationships to chr... | <table><tr><td></td></tr><tr><td>1.</td></tr><tr><td>2.</td></tr><tr><td>3.</td></tr><tr><td>4.</td></tr><tr><td>5.</td></tr><tr><td>6.</td></tr><tr><td>7.</td></tr><tr><td>8.</td></tr></table> | <table><tr><td>Description of framework objectives</td></tr><tr><td>Surveillance to develop shared operational definitions and determinants of mental illness</td></tr><tr><td>Epidemiological research into determinants and protective factors for mental health and their relationships to chronic diseases</td></tr><tr><td>... |
710880b3018f5eb8f539acede6eff451f5f0cd3dfcbb824ec488293e9ad43eb4.png | simple | <table><tr><td>Parameter<sup>†</sup></td><td>Minimum</td><td>Maximum</td><td>Mean</td><td>Standard deviation</td></tr><tr><td>TK</td><td>6 </td><td>73 </td><td>47.47 </td><td>12.7</td></tr><tr><td>LL </td><td>2 </td><td>67 </td><td>39.62 </td><td>12.4 </td></tr><tr><td>TT </td><td>0 </td><td>21 </td><td>7.08 </td... | <table><tr><td>Parameter†</td></tr><tr><td>TK</td></tr><tr><td>LL</td></tr><tr><td>TT</td></tr><tr><td>LT</td></tr><tr><td>PT</td></tr><tr><td>PI</td></tr><tr><td>SS</td></tr></table> | <table><tr><td>Minimum</td><td>Maximum</td><td>Mean</td><td>Standard deviation</td></tr><tr><td>6</td><td>73</td><td>47.47</td><td>12.7</td></tr><tr><td>2</td><td>67</td><td>39.62</td><td>12.4</td></tr><tr><td>0</td><td>21</td><td>7.08</td><td>4.9</td></tr><tr><td>0</td><td>24</td><td>12.09</td><td>5.9</td></tr><tr><td... |
e55ab5e747102986feae08b404bd5c01b918db1bf8acf7c2635573b1ff20f0b8.png | complex | <table><tr><td rowspan="2">Outcome</td><td colspan="2">Regression coefficient(95%CI)</td></tr><tr><td>Publication year</td><td>Type of fractures</td></tr><tr><td>Blood loss</td><td>− 0.02 (− 0.11, 0.08)</td><td>− 0.70 (− 2.04, 0.64)</td></tr><tr><td>Operation time</td><td>− 0.32 (− 0... | <table><tr><td rowspan="2">Outcome</td></tr><tr></tr><tr><td>Blood loss</td></tr><tr><td>Operation time</td></tr></table> | <table><tr><td colspan="2">Regression coefficient(95%CI)</td></tr><tr><td>Publication year</td><td>Type of fractures</td></tr><tr><td>− 0.02 (− 0.11, 0.08)</td><td>− 0.70 (− 2.04, 0.64)</td></tr><tr><td>− 0.32 (− 0.10, 0.04)</td><td>− 0.22 (− 1.28, 0.83)</td></tr></table> |
74af3182eb6791dec6b10d183cbe23cf937d4fed293d0a118346eec0f70d1d31.png | simple | <table><tr><td>Scale</td><td>Fatigue description</td></tr><tr><td>1</td><td>No such feeling</td></tr><tr><td>2</td><td>Negligible feeling</td></tr><tr><td>3</td><td>Some feeling</td></tr><tr><td>4</td><td>Clear feeling</td></tr><tr><td>5</td><td>Strong feeling</td></tr><tr><td>6</td><td>Very strong feeling</td></tr><tr... | <table><tr><td>Scale</td><td>Fatigue description</td></tr></table> | <table><tr><td>1</td><td>No such feeling</td></tr><tr><td>2</td><td>Negligible feeling</td></tr><tr><td>3</td><td>Some feeling</td></tr><tr><td>4</td><td>Clear feeling</td></tr><tr><td>5</td><td>Strong feeling</td></tr><tr><td>6</td><td>Very strong feeling</td></tr><tr><td>7</td><td>Extremely strong feeling</td></tr></... |
44ffb94e5db4d3242ef864e9425cb0d0435eb55be3be34651ace3a99498359ac.png | complex | <table><tr><td colspan="2">C/N<sub>0</sub></td><td>25 dB-Hz</td><td>30 dB-Hz</td><td>35 dB-Hz</td><td>40 dB-Hz</td></tr><tr><td rowspan="3">Standard Receiver</td><td>Optimal Bandwidth</td><td>15 Hz</td><td>22 Hz</td><td>28 Hz</td><td>35 Hz</td></tr><tr><td>Tracking Error of the PLL in Optimal Bandwidth</td><td>28 deg.<... | <table><tr><td colspan="2">C/N0</td><td>25 dB-Hz</td><td>30 dB-Hz</td><td>35 dB-Hz</td><td>40 dB-Hz</td></tr></table> | <table><tr><td rowspan="3">Standard Receiver</td><td>Optimal Bandwidth</td><td>15 Hz</td><td>22 Hz</td><td>28 Hz</td><td>35 Hz</td></tr><tr><td>Tracking Error of the PLL in Optimal Bandwidth</td><td>28 deg.</td><td>15 deg.</td><td>9 deg.</td><td>7 deg.</td></tr><tr><td>Dynamic Stress Noise Proportion (BPLL = 20 Hz)</td... |
be68ba610c313773d33d603ec262428096bf420d41a44b7651fb252ff8430b22.png | complex | <table><tr><td>Variable</td><td colspan="2">Time to report to hospital</td><td rowspan="2">P-value</td><td> </td><td> </td></tr><tr><td> </td><td>Less than one week</td><td>One week and above</td><td>COR*(95 %CI#)</td><td>AOR**(95% CI)</td></tr><tr><td>Age of the child</td><td> </td><td> </td><td> </td><td> </td><td ro... | <table><tr><td>Variable</td><td colspan="2">Time to report to hospital</td><td rowspan="2">P-value</td><td></td><td></td></tr><tr><td></td><td>Less than one week</td><td>One week and above</td><td>COR*(95 %CI#)</td><td>AOR**(95% CI)</td></tr><tr><td>Age of the child</td><td></td><td></td><td></td><td></td><td rowspan="... | <table><tr><td> known to the child?</td><td></td><td></td><td></td><td></td></tr><tr><td>- Yes</td><td>113(69.3)</td><td>82(78.8)</td><td>0.057</td><td>1.64(0.92-2.93)</td></tr><tr><td>- No</td><td>50(30.7)</td><td>22(21.2)</td><td>1</td><td>1</td></tr></table> |
5b57e557412b6f65e642808355b649099129f582d30d27e504e9942fa0661d92.png | complex | <table><tr><td></td><td colspan="2">2006</td><td colspan="2">2007</td><td colspan="2">2008</td></tr><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>United States</td><td>1,025</td><td></td><td>1,021</td><td></td><td>658</td><td></td></tr><tr><td> Any SSM</td><td></td><td>24.4</td><... | <table><tr><td></td><td colspan="2">2006</td><td colspan="2">2007</td><td colspan="2">2008</td></tr><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>United States</td><td>1,025</td><td></td><td>1,021</td><td></td><td>658</td><td></td></tr><tr><td>Any SSM</td><td></td><td>24.4</td><t... | <table><tr><td></td><td colspan="2">2006</td><td colspan="2">2007</td><td colspan="2">2008</td></tr><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>ne</td><td></td><td>0.0</td><td></td><td>2.0</td><td></td><td>.41</td></tr><tr><td>Canada</td><td>975</td><td></td><td>927</td><td></t... |
77fcd9e307b5ffad987a1d9a049aa0ea0ba3d81315cbe855d8d043901949add7.png | complex | <table><tr><td>Characteristic</td><td>Number (%)</td></tr><tr><td>Male (n = 412)</td><td>220 (53)</td></tr><tr><td colspan="2">Role in ED (n = 419)</td></tr><tr><td> Attending</td><td>207 (49)</td></tr><tr><td> Resident</td><td>170 (41)</td></tr><tr><td> Advanced practice provider</td><td>42 (10)</td></tr><tr><td colsp... | <table><tr><td>Characteristic</td><td>Number (%)</td></tr><tr><td>Male (n = 412)</td><td>220 (53)</td></tr><tr><td colspan="2">Role in ED (n = 419)</td></tr><tr><td>Attending</td><td>207 (49)</td></tr><tr><td>Resident</td><td>170 (41)</td></tr><tr><td>Advanced practice provider</td><td>42 (10)</td></tr><tr><td colspan=... | <table><tr><td>Prior therapeutic OA use (n=420)</td><td>265 (63)</td></tr></table> |
9a83015468ca5992f747fd373c45a9f5d42457740b61068e902867376ced850d.png | simple | <table><tr><td>Tissue</td><td>Content of poncirin (mg/g FW)</td></tr><tr><td>flavedo</td><td>0.15 ± 0.01</td></tr><tr><td>albedo</td><td>1.37 ± 0.09</td></tr><tr><td>segment membrane</td><td>0.52 ± 0.01</td></tr><tr><td>juice sac</td><td>0.07 ± 0.01</td></tr></table> | <table><tr><td>Tissue</td><td>Content of poncirin (mg/g FW)</td></tr><tr><td>flavedo</td><td>0.15 ± 0.01</td></tr></table> | <table><tr><td>Tissue</td><td>Content of poncirin (mg/g FW)</td></tr><tr><td>albedo</td><td>1.37 ± 0.09</td></tr><tr><td>segment membrane</td><td>0.52 ± 0.01</td></tr><tr><td>juice sac</td><td>0.07 ± 0.01</td></tr></table> |
f7d1582fc0a87d823d6f3e0f27a642fa636c49d895f924068386356b444fe51f.png | simple | <table><tr><td>Problem</td><td>Possible Reason</td><td>Solution</td></tr><tr><td>Genome is not fragmented after sonication.</td><td>Buffer condition is not adaptable for sonication.</td><td>Purify the DNA. We used QIAGEN PCR Purification Kit, eluted in EB to have it work.</td></tr><tr><td>Nothing is visible on the gel ... | <table><tr><td>Problem</td><td>Possible Reason</td><td>Solution</td></tr></table> | <table><tr><td>Genome is not fragmented after sonication.</td><td>Buffer condition is not adaptable for sonication.</td><td>Purify the DNA. We used QIAGEN PCR Purification Kit, eluted in EB to have it work.</td></tr><tr><td>Nothing is visible on the gel after 1 hr electrophoresis during library generation.</td><td>When... |
b49432c62a1156818cbb2db54b6bf68e08b5f530660370c911da5856483c6f24.png | complex | <table><tr><td rowspan="2">Dietary Intake Adequacy Based on Mean Adequacy Ratio (MAR)</td><td>Minimum Dietary Diversity</td><td>Minimum Meal Frequency</td><td>Minimum Acceptable Diet</td><td>Consumption of Iron-Rich/Fortified Food</td></tr><tr><td colspan="4">Odds Ratio (95% CI)</td></tr><tr><td><sup>b</sup> MAR > 0... | <table><tr><td rowspan="2">Dietary Intake Adequacy Based on Mean Adequacy Ratio (MAR)</td><td>Minimum Dietary Diversity</td><td>Minimum Meal Frequency</td><td>Minimum Acceptable Diet</td><td>Consumption of Iron-Rich/Fortified Food</td></tr><tr><td colspan="4">Odds Ratio (95% CI)</td></tr><tr><td>b MAR > 0.6 (more than ... | <table><tr><td rowspan="2">Dietary Intake Adequacy Based on Mean Adequacy Ratio (MAR)</td><td>Minimum Dietary Diversity</td><td>Minimum Meal Frequency</td><td>Minimum Acceptable Diet</td><td>Consumption of Iron-Rich/Fortified Food</td></tr><tr><td colspan="4">Odds Ratio (95% CI)</td></tr><tr><td>0.5 < a MAR ≤ 0.6 (50.1... |
a8d17825c60a3a55c9b188d675d92df4e650a9542cfd1ed69d9bab8114bf1305.png | complex | <table><tr><td rowspan="2">ScheduleTreatment day (TD)Time point (T)</td><td rowspan="2">T0 (Screening, baseline and prediagnosis tests)</td><td colspan="7">T1 (Treatment and discharge)</td><td rowspan="2">T2 3M</td><td rowspan="2">T3 6M</td><td rowspan="2">T4 12M</td><td rowspan="2">Withdrawal</td></tr><tr><td>TD 1*</t... | <table><tr><td rowspan="2">ScheduleTreatment day (TD)Time point (T)</td><td rowspan="2">T0 (Screening, baseline and prediagnosis tests)</td><td colspan="7">T1 (Treatment and discharge)</td><td rowspan="2">T2 3M</td><td rowspan="2">T3 6M</td><td rowspan="2">T4 12M</td><td rowspan="2">Withdrawal</td></tr><tr><td>TD 1*</t... | <table><tr><td rowspan="2">ScheduleTreatment day (TD)Time point (T)</td><td rowspan="2">T0 (Screening, baseline and prediagnosis tests)</td><td colspan="7">T1 (Treatment and discharge)</td><td rowspan="2">T2 3M</td><td rowspan="2">T3 6M</td><td rowspan="2">T4 12M</td><td rowspan="2">Withdrawal</td></tr><tr><td>TD 1*</t... |
ec6bd9e6f6814f3db264a58330e15179f9d95ff292c577fcfd6902c79251770b.png | simple | <table><tr><td>Study</td><td>Number of patients</td><td>Follow-up (days)</td><td>Baseline comparison</td><td>Adverse event</td><td>Outcomes measure (primary/secondary)</td><td>Treatment group dosage</td><td>Types of stroke</td></tr><tr><td>Cai et al. 2000 [29]</td><td>256</td><td>14</td><td>Y</td><td>N</td><td>TER, CSS... | <table><tr><td>Study</td><td>Number of patients</td><td>Follow-up (days)</td><td>Baseline comparison</td><td>Adverse event</td><td>Outcomes measure (primary/secondary)</td><td>Treatment group dosage</td><td>Types of stroke</td></tr><tr><td>Cai et al. 2000 [29]</td><td>256</td><td>14</td><td>Y</td><td>N</td><td>TER, CSS... | <table><tr><td>Lei 2013 [33]</td><td>120</td><td>28</td><td>Y</td><td>Y</td><td>TER</td><td>XNJ 20 mL/d + CWM</td><td>ICH</td></tr><tr><td>Li 2011 [34]</td><td>118</td><td>14</td><td>Y</td><td>N</td><td>TNF-α, IL-6, NIHSS</td><td>XNJ 40 mL/d + CWM</td><td>ICH</td></tr><tr><td>Liu and Bai 2004 [35]</td><td>70</td><td>14... |
286b103c369fad5f7b929cf626e533fdb6b0624993c241dd6965797156685fce.png | simple | <table><tr><td></td><td>No Bone Graft(n = 18)</td><td>Bone Graft(n = 29)</td><td><i>p value</i></td></tr><tr><td>Pain severity, neck</td><td>10.37</td><td>17.01</td><td><i>0.139</i></td></tr><tr><td>Pain severity, arm</td><td>7.22</td><td>6.44</td><td><i>0.628</i></td></tr><tr><td>Functional disability</td><td>18.78</t... | <table><tr><td></td><td>No Bone Graft(n = 18)</td><td>Bone Graft(n = 29)</td><td>p value</td></tr><tr><td>Pain severity, neck</td><td>10.37</td><td>17.01</td><td>0.139</td></tr><tr><td>Pain severity, arm</td><td>7.22</td><td>6.44</td><td>0.628</td></tr><tr><td>Functional disability</td><td>18.78</td><td>21.01</td><td>0... | <table><tr><td></td><td>No Bone Graft(n = 18)</td><td>Bone Graft(n = 29)</td><td>p value</td></tr><tr><td>Psychological distress</td><td>19.14</td><td>38.37</td><td>0.024</td></tr><tr><td>Physical symptoms other than neck/arm pain</td><td>12.96</td><td>18.07</td><td>0.344</td></tr><tr><td>Healthcare utilisation</td><td... |
886197977c4b95eec5eed00a58a172779a219447212d99343d0725119d13dfd2.png | simple | <table><tr><td></td><td>CA-AKI and RIFLE (<i>n</i> = 14)</td><td>CA-AKI (<i>n</i> = 9)</td><td>Only RIFLE (<i>n</i> = 31)</td><td>No CA-AKI (<i>n</i> = 95)</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>73 [61–80]</td><td>60 [48–67]</td><td>68 [57–75]</td><td>63 [55–71]</td><td>0.08... | <table><tr><td></td><td>CA-AKI and RIFLE (n = 14)</td><td>CA-AKI (n = 9)</td><td>Only RIFLE (n = 31)</td><td>No CA-AKI (n = 95)</td><td>P value</td></tr><tr><td>Age (years)</td><td>73 [61–80]</td><td>60 [48–67]</td><td>68 [57–75]</td><td>63 [55–71]</td><td>0.08</td></tr><tr><td>Sex (male/female)</td><td>10/4</td><td>6/... | <table><tr><td></td><td>CA-AKI and RIFLE (n = 14)</td><td>CA-AKI (n = 9)</td><td>Only RIFLE (n = 31)</td><td>No CA-AKI (n = 95)</td><td>P value</td></tr><tr><td>Maximal vasopressor dose, day 2 (mcg/kg/min)</td><td>0.19 [0.00–0.40]*</td><td>0.00 [0.00–0.04]</td><td>0.00 [0.00–0.08]</td><td>0.00 [0.00–0.00]</td><td><0.00... |
641ab38659c6f8338db003df48679d42c394386440b9bf6ddaa594e0492bb4a1.png | simple | <table><tr><td>Step</td><td>(min) Time</td><td>(W) Power</td><td>Temp. (°C)</td></tr><tr><td>1</td><td>15</td><td>450</td><td>195</td></tr><tr><td>2</td><td>2.0</td><td>0</td><td>190</td></tr><tr><td>3</td><td>10</td><td>300</td><td>195</td></tr><tr><td>4</td><td>15</td><td>350</td><td>195</td></tr></table> | <table><tr><td>Step</td><td>(min) Time</td><td>(W) Power</td><td>Temp. (°C)</td></tr><tr><td>1</td><td>15</td><td>450</td><td>195</td></tr><tr><td>2</td><td>2.0</td><td>0</td><td>190</td></tr><tr><td>3</td><td>10</td><td>300</td><td>195</td></tr></table> | <table><tr><td>Step</td><td>(min) Time</td><td>(W) Power</td><td>Temp. (°C)</td></tr><tr><td>4</td><td>15</td><td>350</td><td>195</td></tr></table> |
230054d5393c4df43005d72ca8f7c4e357a7addd20329572ec649947ea439994.png | simple | <table><tr><td>Locality</td><td>Taxon</td><td>Site</td><td>Latitude</td><td>Longitude</td><td>Depth (m)</td><td>No. of tube fragments*</td></tr><tr><td>Antarctic</td><td><i>Sclerolinum</i> sp.</td><td>Hook Ridge Site 1</td><td>−62.1969</td><td>−57.2975</td><td>1174</td><td>686*</td></tr><tr><td></td><td></t... | <table><tr><td>Locality</td><td>Taxon</td><td>Site</td><td>Latitude</td><td>Longitude</td><td>Depth (m)</td><td>No. of tube fragments*</td></tr><tr><td>Antarctic</td><td>Sclerolinum sp.</td><td>Hook Ridge Site 1</td><td>−62.1969</td><td>−57.2975</td><td>1174</td><td>686*</td></tr><tr><td></td><td></td><td>Hook Ridge Si... | <table><tr><td>Locality</td><td>Taxon</td><td>Site</td><td>Latitude</td><td>Longitude</td><td>Depth (m)</td><td>No. of tube fragments*</td></tr><tr><td>Arctic</td><td>S. contortum</td><td>Loki’s Castle CG2009</td><td>73.5662</td><td>8.1585</td><td>2357</td><td>33*</td></tr><tr><td></td><td></td><td>Loki’s Castle CG2008... |
ae75da9e746c5b6fcffb01f39bb20ed1c7279df2b85b5d6263aef0eadde38079.png | complex | <table><tr><td rowspan="2">Data source</td><td colspan="3"># of annotated exons</td><td colspan="3"># of mapped exon</td></tr><tr><td>Ensembl-rheMac2</td><td>GASS</td><td>RefSeq -rheMac3</td><td>Ensembl-rheMac2</td><td>GASS</td><td>RefSeq-rheMac3</td></tr><tr><td>SRR299127</td><td rowspan="3">122,454</td><td rowspan="3... | <table><tr><td>Data source</td><td colspan="3"># of annotated exons</td><td colspan="3"># of mapped exon</td></tr></table> | <table><tr><td>Data source</td><td>Ensembl-rheMac2</td><td>GASS</td><td>RefSeq -rheMac3</td><td>Ensembl-rheMac2</td><td>GASS</td><td>RefSeq-rheMac3</td></tr><tr><td>SRR299127</td><td rowspan="3">122,454</td><td rowspan="3">146,364</td><td rowspan="3">45,540</td><td>16,696(13.63%)</td><td>24,001 (16.40%)</td><td>9,341(2... |
822e3d2ea9e6adf2b2cc75ba89b9eca367d691f8d8fbeef130850daa0011279e.png | complex | <table><tr><td rowspan="2">ID</td><td rowspan="2">Gender</td><td rowspan="2">Age</td><td rowspan="2">TNM</td><td rowspan="2">Tumor sublocation</td><td rowspan="2">Chemotherapy</td><td colspan="3">Volume (cm<sup>3</sup>)</td><td colspan="2">Mean planned PG dose (Gy)</td><td colspan="2">Xerostomia NTCP (%) [23, 24]</td><... | <table><tr><td rowspan="2">ID</td><td rowspan="2">Gender</td></tr><tr></tr><tr><td>1</td><td>M</td></tr><tr><td>2</td><td>F</td></tr><tr><td>3</td><td>M</td></tr><tr><td>4</td><td>F</td></tr><tr><td>5</td><td>M</td></tr><tr><td>6</td><td>M</td></tr><tr><td>7</td><td>M</td></tr><tr><td>8</td><td>M</td></tr><tr><td>9</td... | <table><tr><td rowspan="2">Age</td><td rowspan="2">TNM</td><td rowspan="2">Tumor sublocation</td><td rowspan="2">Chemotherapy</td><td colspan="3">Volume (cm3)</td><td colspan="2">Mean planned PG dose (Gy)</td><td colspan="2">Xerostomia NTCP (%) [23, 24]</td></tr><tr><td>CTV70</td><td>ILP</td><td>CLP</td><td>ILP</td><td... |
1afb1d0799ac6996d4cb7eed0fd6b25cba1d2d6fc25853dd4eafeb0a9ed8d327.png | complex | <table><tr><td rowspan="2"></td><td></td><td colspan="3">Recalling and understanding (part A)</td><td colspan="3">Applying (part B)</td><td colspan="3">Total (part A & B)</td></tr><tr><td><i>N</i></td><td><i>M</i></td><td><i>SD</i></td><td>Min–max</td><td><i>M</i></td><td><i>SD</i></td><td>Min–max</td><... | <table><tr><td rowspan="2"></td><td></td><td colspan="3">Recalling and understanding (part A)</td><td colspan="3">Applying (part B)</td><td colspan="2">Total (part A & B)</td></tr><tr><td>N</td><td>M</td><td>SD</td><td>Min–max</td><td>M</td><td>SD</td><td>Min–max</td><td>M</td><td>SD</td></tr><tr><td>Pre-test</td><td>7... | <table><tr><td>Total (part A & B)</td></tr><tr><td>Min–max</td></tr><tr><td>3–6</td></tr><tr><td>5–9</td></tr><tr><td>5–11</td></tr></table> |
f25b87020e4f7779e57fdf42728dbeeac6af48d874ab87c51749147e9e1adeb1.png | simple | <table><tr><td>Farm</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>nr. of samples</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td></tr><tr><td>nr. of PRM/sample</td><td>50</td><td>50-100</td><td>100</td><td>50</td><td>50</td><... | <table><tr><td>Farm</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>nr. of samples</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td></tr><tr><td>nr. of PRM/sample</td><td>50</td><td>50-100</td><td>100</td><td>50</td><td>50</td><... | <table><tr><td>Farm</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>yers on the farm</td><td>o</td><td>Yes</td><td></td><td>s</td><td>Yes</td><td>Yes</td><td>es</td><td></td></tr><tr><td>nr. of layers on the farm</td><td>0*</td><td>6,000</td><td>12,000</td><td>15,000</td... |
77c03afb3b610d87ed502d0f82baf5c7e5cb82af3fdef4d840b46dec3231b2c9.png | simple | <table><tr><td></td><td>Percentage agree or strongly agree (n = 37)</td></tr><tr><td>Knowledge translation was hampered by a lack of incentives for KTE activities within organisations that conduct health systems and policy research (HSPR)</td><td>38</td></tr><tr><td>Organisations that conduct HSPR made available financ... | <table><tr><td></td><td>Percentage agree or strongly agree (n = 37)</td></tr><tr><td>Knowledge translation was hampered by a lack of incentives for KTE activities within organisations that conduct health systems and policy research (HSPR)</td><td>38</td></tr></table> | <table><tr><td>Organisations that conduct HSPR made available financial and human resources to assist with KTE activities</td><td>24</td></tr><tr><td>Organisations that conduct HSPR were not seen as a credible source of research</td><td>14</td></tr></table> |
4051725750cb3b7738db0d2f42ffaa13fc8b05390079c9a802cbcbaf02cf5491.png | complex | <table><tr><td></td><td colspan="2">2012 (<i>N = 18,558</i>)</td><td colspan="2">2006 (<i>N = 12,443</i>)</td><td colspan="2">2000 (<i>N = 9,049</i>)</td><td colspan="2">1994 (<i>N = 8,864</i>)</td></tr><tr><td>Age group</td><td>Male (%)</td><td>Female (%)</td><td>Male (%)</td><td>Female (%)</td><td>Male (%)</td><td>Fe... | <table><tr><td></td><td colspan="2">2012 (N = 18,558)</td><td colspan="2">2006 (N = 12,443)</td><td colspan="2">2000 (N = 9,049)</td><td colspan="2">1994 (N = 8,864)</td></tr><tr><td>Age group</td><td>Male (%)</td><td>Female (%)</td><td>Male (%)</td><td>Female (%)</td><td>Male (%)</td><td>Female (%)</td><td>Male (%)</t... | <table><tr><td>Geography of residence (%)</td><td colspan="2"></td><td colspan="2"></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td>Urban</td><td colspan="2">68.06</td><td colspan="2">68.79</td><td colspan="2">65.12</td><td colspan="2">70.23</td></tr><tr><td>Rural</td><td colspan="2">31.94</td><td colspan="2... |
c9c4b3275e6736b47685a6c0e45f62c619624d815c76ff6063f9ba07e6f0da06.png | complex | <table><tr><td colspan="2"> </td><td> </td><td>ID code</td><td>Sex</td><td>Age (Years)</td><td>Time in facility (Years)</td><td>Staff position</td></tr><tr><td colspan="3">Dyads</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td colspan="2">Dyad 1</td><td> </td><td> </td><td> </td><td> </td><t... | <table><tr><td colspan="2"></td><td></td><td>ID code</td><td>Sex</td><td>Age (Years)</td><td>Time in facility (Years)</td><td>Staff position</td></tr><tr><td colspan="3">Dyads</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td colspan="2">Dyad 1</td><td></td><td></td><td></td><td></td><td></td></tr>... | <table><tr><td colspan="2"></td><td></td><td>ID code</td><td>Sex</td><td>Age (Years)</td><td>Time in facility (Years)</td><td>Staff position</td></tr><tr><td></td><td></td><td>Resident</td><td>R3</td><td>M</td><td>89</td><td>1</td><td></td></tr><tr><td></td><td></td><td>Family</td><td>F3</td><td>F</td><td>43</td><td></... |
5969ca2d8d96b9806326c49a2017f9d6b864ee68dafea1766506d0744b1f7187.png | simple | <table><tr><td>Mitochondrial abnormality</td><td>MS</td><td>CFS</td><td>PD</td><td>AUT</td><td>MDD</td><td>Schiz</td><td>BPD</td></tr><tr><td>Ultrastructural abnormalities in mitochondria</td><td>+</td><td>++</td><td>+</td><td>+</td><td>+</td><td>+++</td><td>+</td></tr><tr><td>Evidence to shift in energy production via... | <table><tr><td>Mitochondrial abnormality</td><td>MS</td><td>CFS</td><td>PD</td><td>AUT</td><td>MDD</td><td>Schiz</td><td>BPD</td></tr></table> | <table><tr><td>Ultrastructural abnormalities in mitochondria</td><td>+</td><td>++</td><td>+</td><td>+</td><td>+</td><td>+++</td><td>+</td></tr><tr><td>Evidence to shift in energy production via glycolysis</td><td>+</td><td>++</td><td>++</td><td>++</td><td></td><td>++</td><td>++</td></tr><tr><td>Mitochondrial dysfunctio... |
c68fbc847851e594e55be12c5212f51ce67a296a904614e788e8a86f2a6d2ca3.png | simple | <table><tr><td> </td><td>T1</td><td>T2</td><td>T3</td><td>T4</td><td>T5</td></tr><tr><td>Case 1</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> SNA</td><td>82.7</td><td>82.6</td><td>81.3</td><td>81.7</td><td>81.8</td></tr><tr><td> SNB</td><td>68.0</td><td>68.7</td><td>70.1</td><td>70.2</td><td>71.4<... | <table><tr><td></td><td>T1</td><td>T2</td><td>T3</td><td>T4</td><td>T5</td></tr><tr><td>Case 1</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>SNA</td><td>82.7</td><td>82.6</td><td>81.3</td><td>81.7</td><td>81.8</td></tr></table> | <table><tr><td></td><td>T1</td><td>T2</td><td>T3</td><td>T4</td><td>T5</td></tr><tr><td>SNB</td><td>68.0</td><td>68.7</td><td>70.1</td><td>70.2</td><td>71.4</td></tr><tr><td>ANB</td><td>14.7</td><td>13.8</td><td>11.3</td><td>11.5</td><td>10.4</td></tr><tr><td>SN-Pog</td><td>65.8</td><td>70.1</td><td>69.1</td><td>69.1</... |
cb0ea8b5f810bfdc9b3ecec756b38b6408cab38ed854fcb3b292daed56fd43e4.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Age/Gender</td><td rowspan="2">Experience in Using EPW</td><td colspan="2">Type of Disabilities</td></tr><tr><td>Motor</td><td>Cognition</td></tr><tr><td>User I</td><td>60-year-old male</td><td>Yes</td><td>Lower body amputation by diabetes</td><td>Low cognition/reflexes b... | <table><tr><td rowspan="2"></td><td rowspan="2">Age/Gender</td><td rowspan="2">Experience in Using EPW</td><td colspan="2">Type of Disabilities</td></tr><tr><td>Motor</td><td>Cognition</td></tr><tr><td>User I</td><td>60-year-old male</td><td>Yes</td><td>Lower body amputation by diabetes</td><td>Low cognition/reflexes b... | <table><tr><td rowspan="2"></td><td rowspan="2">Age/Gender</td><td rowspan="2">Experience in Using EPW</td><td colspan="2">Type of Disabilities</td></tr><tr><td>Motor</td><td>Cognition</td></tr><tr><td>User V</td><td>28-year-old female</td><td>Yes</td><td>Spinal cord injury</td><td>-</td></tr></table> |
095883369f809bbf0f5e6d41acfe93371ad219dd7b01e1a755a8c5b1a7fc229b.png | simple | <table><tr><td>Group</td><td>EPG</td><td>Egg reduction rate (%)</td></tr><tr><td>PBS (<i>n</i> = 5)</td><td>76.60 ± 7.427</td><td>–</td></tr><tr><td><i>B.s</i>-CotC (n <i>=</i> 5)</td><td>74.80 ± 8.194</td><td>–</td></tr><tr><td>Oral (n <i>=</i> 5)<sup>a</sup></td><td>39.60 ± 3.945<sup>**</su... | <table><tr><td>Group</td><td>EPG</td><td>Egg reduction rate (%)</td></tr><tr><td>PBS (n = 5)</td><td>76.60 ± 7.427</td><td>–</td></tr><tr><td>B.s-CotC (n</td><td>74.80 ± 8</td><td>–</td></tr></table> | <table><tr><td>Group</td><td>EPG</td><td>Egg reduction rate (%)</td></tr><tr><td> = 5)</td><td>.194</td><td></td></tr><tr><td>Oral (n = 5)a</td><td>39.60 ± 3.945**</td><td>48.30</td></tr><tr><td>Injected (n = 5)b</td><td>37.40 ± 3.647**</td><td>51.20</td></tr></table> |
1b049c1c3c77b93523c1ccf2087df32eb3c4cf55d43a41436ac6a7be64102d70.png | complex | <table><tr><td rowspan="2"> Diagnosis</td><td>12 to 14 years old</td><td>15 to 17 years old</td></tr><tr><td>(<i>n</i> = 9)</td><td>(<i>n</i> = 7)</td></tr><tr><td>ADHD</td><td>3</td><td>1</td></tr><tr><td>ODD</td><td></td><td>2</td></tr><tr><td>MDD</td><td></td><td>2</td></tr><tr><td>PTSD</td><td>1</td><td></td></tr><... | <table><tr><td rowspan="2">Diagnosis</td><td>12 to 14 years old</td><td>15 to 17 years old</td></tr><tr><td>(n = 9)</td><td>(n = 7)</td></tr><tr><td>ADHD</td><td>3</td><td>1</td></tr><tr><td>ODD</td><td></td><td>2</td></tr><tr><td>MDD</td><td></td><td>2</td></tr><tr><td>PTSD</td><td>1</td><td></td></tr><tr><td>Social p... | <table><tr><td rowspan="2">Diagnosis</td><td>12 to 14 years old</td><td>15 to 17 years old</td></tr><tr><td>(n = 9)</td><td>(n = 7)</td></tr><tr><td>ADHD/MDD</td><td></td><td>2</td></tr><tr><td>ADHD/PTSD/ODD</td><td>1</td><td></td></tr></table> |
dedd8ed8872c1013c172db3e68cd3b72b9df9b763efb9bd505a342dc49f71ec2.png | complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">Classification of chronic malnutrition</td><td rowspan="2">Test statistic</td></tr><tr><td>Normal % [95 % confidence interval]</td><td>Stunted % [95 % confidence interval]</td></tr><tr><td>Religion of mother</td><td></td><td></td><td></td></tr><tr><td> Chris... | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">Classification of chronic malnutrition</td><td rowspan="2">Test statistic</td></tr><tr><td>Normal % [95 % confidence interval]</td><td>Stunted % [95 % confidence interval]</td></tr><tr><td>Religion of mother</td><td></td><td></td><td></td></tr><tr><td>Christ... | <table><tr><td>CWC Attendance</td><td></td><td></td><td></td></tr><tr><td>1-2</td><td>76.3 [CI: 72.1 – 80.0]</td><td>23.7 [CI: 20.0 – 27.9]</td><td rowspan="3">χ2 = 6.7 , p = 0.03</td></tr><tr><td>3-4</td><td>80.6 [CI: 77.5 – 83.4]</td><td>19.4 [CI: 16.6 – 22.5]</td></tr><tr><td>4+</td><td>94.7[CI: 80.8 – 98.7]</td><td... |
7c61a2564a3084f8406f37b4dcabf4054a982c390341602f16765ebc200761de.png | simple | <table><tr><td>Genus/subgenus</td><td>Species</td><td>No. of unique conotoxin precursors</td><td>No. of unique mature toxins</td><td>No. of gene superfamilies</td><td>No. of cysteine frameworks</td><td>Most abundant gene superfamily and frequency<sup>a</sup></td><td>Main diet summarized from [29, 42]</td></tr><tr><td><... | <table><tr><td>Genus/subgenus</td><td>Species</td><td>No. of unique conotoxin precursors</td><td>No. of unique mature toxins</td><td>No. of gene superfamilies</td><td>No. of cysteine frameworks</td><td>Most abundant gene superfamily and frequencya</td><td>Main diet summarized from [29, 42]</td></tr><tr><td>Puncticulis<... | <table><tr><td>Genus/subgenus</td><td>Species</td><td>No. of unique conotoxin precursors</td><td>No. of unique mature toxins</td><td>No. of gene superfamilies</td><td>No. of cysteine frameworks</td><td>Most abundant gene superfamily and frequencya</td><td>Main diet summarized from [29, 42]</td></tr><tr><td>Virroconus</... |
1d106221768068eadd6f37589bf5f8e35c6ddf27f9818e083dd333f92d8bc44a.png | complex | <table><tr><td></td><td colspan="4">Customers-Suppliers vignettes</td><td colspan="4">Employees-Suppliers vignettes</td><td colspan="4">Employees-Environment vignettes</td></tr><tr><td></td><td>Effect</td><td>SE</td><td>LL95%CI</td><td>UL95%CI</td><td>Effect</td><td>SE</td><td>LL95%CI</td><td>UL95%CI</td><td>Effect</td... | <table><tr><td></td><td colspan="4">Customers-Suppliers vignettes</td><td colspan="4">Employees-Suppliers vignettes</td><td colspan="4">Employees-Environment vignettes</td></tr><tr><td></td><td>Effect</td><td>SE</td><td>LL95%CI</td><td>UL95%CI</td><td>Effect</td><td>SE</td><td>LL95%CI</td><td>UL95%CI</td><td>Effect</td... | <table><tr><td>SD</td><td></td><td></td><td>6</td><td>.40</td><td>27</td><td>0.18</td><td>.07</td><td></td><td>1</td><td>100</td><td>.46</td><td>0.06</td></tr><tr><td>Mean</td><td>0.37</td><td>0.08</td><td>0.22</td><td>0.55</td><td>0.46</td><td>0.10</td><td>0.27</td><td>0.68</td><td>−0.15</td><td>0.07</td><td>−0.32</td... |
7ec163a5de7a11912cb13dc5f8444c32827c50555ad74877249dfe221f0edc21.png | simple | <table><tr><td>Symptoms</td><td>EG</td><td>YG</td><td><i>P</i></td></tr><tr><td>Heartburn</td><td>1.6 ± 0.89</td><td>2.8 ± 0.76</td><td><0.05</td></tr><tr><td>Acid regurgitation</td><td>1.6 ± 0.98</td><td>2.4 ± 0.91</td><td><0.05</td></tr><tr><td>Solid food dysphagia</td><td>1.7 ± 0.78</t... | <table><tr><td>Symptoms</td><td>EG</td><td>YG</td><td>P</td></tr><tr><td>Heartburn</td><td>1.6 ± 0.89</td><td>2.8 ± 0.76</td><td><0.05</td></tr><tr><td>Ac</td><td>1.</td><td>2.4 ± 0.91</td><td><0.</td></tr></table> | <table><tr><td>id regurgitation</td><td>6 ± 0.98</td><td></td><td>05</td></tr><tr><td>Solid food dysphagia</td><td>1.7 ± 0.78</td><td>0.6 ± 0.22</td><td><0.05</td></tr><tr><td>Chest pain</td><td>1.7 ± 0.84</td><td>1.5 ± 0.89</td><td>>0.05</td></tr><tr><td>Respiratory complication</td><td>1.9 ± 1.06</td><td>1.1 ± 0.47</... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.